WO2014184340A1 - Composition of ilex aquifolium extracts and use thereof - Google Patents
Composition of ilex aquifolium extracts and use thereof Download PDFInfo
- Publication number
- WO2014184340A1 WO2014184340A1 PCT/EP2014/060070 EP2014060070W WO2014184340A1 WO 2014184340 A1 WO2014184340 A1 WO 2014184340A1 EP 2014060070 W EP2014060070 W EP 2014060070W WO 2014184340 A1 WO2014184340 A1 WO 2014184340A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mpa
- extract
- plant
- alkyl group
- genus
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 164
- 239000000284 extract Substances 0.000 title claims abstract description 63
- 241000209035 Ilex Species 0.000 title claims abstract description 26
- 235000003332 Ilex aquifolium Nutrition 0.000 title claims abstract description 21
- 238000009472 formulation Methods 0.000 claims abstract description 59
- 241000196324 Embryophyta Species 0.000 claims abstract description 52
- 239000000419 plant extract Substances 0.000 claims abstract description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 88
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 39
- 239000003921 oil Substances 0.000 claims description 35
- 239000012188 paraffin wax Substances 0.000 claims description 32
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 241000546188 Hypericum Species 0.000 claims description 29
- 240000005893 Pteridium aquilinum Species 0.000 claims description 25
- 235000009936 Pteridium aquilinum Nutrition 0.000 claims description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 24
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 20
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 20
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 20
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 20
- 241001453830 Pteridium Species 0.000 claims description 18
- 239000000047 product Substances 0.000 claims description 16
- 238000002803 maceration Methods 0.000 claims description 15
- 239000006228 supernatant Substances 0.000 claims description 15
- 238000000227 grinding Methods 0.000 claims description 14
- 229960005150 glycerol Drugs 0.000 claims description 12
- 235000011187 glycerol Nutrition 0.000 claims description 12
- 238000010908 decantation Methods 0.000 claims description 11
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 10
- 244000141009 Hypericum perforatum Species 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 10
- -1 n-tridecanyl group Chemical group 0.000 claims description 9
- 238000003306 harvesting Methods 0.000 claims description 8
- 238000005119 centrifugation Methods 0.000 claims description 7
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 claims description 6
- 235000011184 guayusa Nutrition 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 239000003974 emollient agent Substances 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 150000004665 fatty acids Chemical class 0.000 claims description 5
- 229920006395 saturated elastomer Polymers 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 238000011282 treatment Methods 0.000 abstract description 20
- 241001465754 Metazoa Species 0.000 abstract description 17
- 235000003325 Ilex Nutrition 0.000 abstract description 5
- 244000144972 livestock Species 0.000 abstract description 2
- 241000893966 Trichophyton verrucosum Species 0.000 description 16
- 241000283690 Bos taurus Species 0.000 description 12
- 239000005662 Paraffin oil Substances 0.000 description 12
- 208000002474 Tinea Diseases 0.000 description 11
- 241001480037 Microsporum Species 0.000 description 6
- 241000223238 Trichophyton Species 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000035876 healing Effects 0.000 description 5
- 229940055035 trichophyton verrucosum Drugs 0.000 description 5
- 241000283086 Equidae Species 0.000 description 4
- 206010017533 Fungal infection Diseases 0.000 description 4
- 230000006735 deficit Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 3
- PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 PZBPKYOVPCNPJY-UHFFFAOYSA-N 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 206010008803 Chromoblastomycosis Diseases 0.000 description 3
- 241000222290 Cladosporium Species 0.000 description 3
- 241000187845 Dermatophilus congolensis Species 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 239000005795 Imazalil Substances 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 241000222831 Phialophora <Chaetothyriales> Species 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 230000001143 conditioned effect Effects 0.000 description 3
- 229960002125 enilconazole Drugs 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 201000002266 mite infestation Diseases 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000156961 Coenonympha Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- 235000003321 Ilex vomitoria Nutrition 0.000 description 2
- 241000209026 Ilex vomitoria Species 0.000 description 2
- 241000289658 Insectivora Species 0.000 description 2
- 241001260008 Microsporum equinum Species 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 241000893976 Nannizzia gypsea Species 0.000 description 2
- 241000264375 Nannizzia nana Species 0.000 description 2
- 241000921804 Nannizzia persicolor Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 241000893962 Trichophyton equinum Species 0.000 description 2
- 241001045773 Trichophyton erinacei Species 0.000 description 2
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 2
- 241001609979 Trichophyton quinckeanum Species 0.000 description 2
- 241000223229 Trichophyton rubrum Species 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 208000024386 fungal infectious disease Diseases 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000003276 Apios tuberosa Nutrition 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000010744 Arachis villosulicarpa Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 235000003368 Ilex paraguariensis Nutrition 0.000 description 1
- 244000188472 Ilex paraguariensis Species 0.000 description 1
- 241000893980 Microsporum canis Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241001533598 Septoria Species 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001355 anti-mycobacterial effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000010690 paraffinic oil Substances 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- BCLQDYWZPAKKFD-UHFFFAOYSA-N propan-2-yl tetradecanoate;2-propan-2-yltetradecanoic acid Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C.CCCCCCCCCCCCC(C(C)C)C(O)=O BCLQDYWZPAKKFD-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Definitions
- the present invention relates to the use of plant extracts or mixtures of plant extracts, in particular an extract of a plant of the genus // ex, preferably an extract of // ex aquifolium.
- plant extracts or plant extract mixtures are particularly advantageous for the treatment of diseases, especially dermatological conditions, or for their soothing or cleansing properties of the epidermis of animals, especially animals of breeding.
- the invention also relates to a concentrated composition and a formulation adapted to these uses.
- Soothing, healing, disinfecting or emollient Soothing, healing, disinfecting or emollient.
- WO-2005/063266 relates to a dermatological composition comprising extracts of Hypericum perforatum and Calendula officinalis. The more specific treatment of psoriasis is aimed at.
- Erdemoglu et al. described the screening of extracts of dry leaves of ex-aquifolium (Erdemoglu et al., Antibacterial, antifungal and antimycobacterial activity of llexacifolium, 2009).
- Another difficulty relates to the choice of the plants to be associated with each other in order to improve the properties thereof.
- the present invention provides a solution to all or part of these problems.
- the present invention therefore relates to a concentrated composition
- a concentrated composition comprising at least one extract of a plant of the genus llex in a concentration ranging from 5 to 80 g / l.
- the present invention also relates to a concentrated composition
- a concentrated composition comprising at least one extract of a plant of the genus llex in a concentration ranging from 5 to 80 g / l, excluding a fruit extract of a plant of the genus llex.
- the concentrated composition according to the invention comprises at least one extract of fresh leaves or fresh frozen leaves of a plant of the genus llex in a concentration ranging from 5 to 80 g / l.
- the plant extract within the composition according to the invention is derived from a plant selected from llex aquifolium, llex aquiliformis, llex guayusa, llex paraguariensis, llex vomitoria, or from a selected plant. among llex aquifolium, llex aquiliformis, llex guayusa, llex vomitoria, preferably it is an extract of Hex aquifolium.
- the concentration of llex plant extract can range from 15 to 60 g / l or from 25 to 45 g / l.
- the concentrated composition according to the invention also comprises at least one extract of a plant of the genus Pteridium or at least one extract of a plant of the genus Hypericum. More preferably, the concentrated composition according to the invention also comprises at least one extract of a plant of the genus Pteridium and at least one extract of a plant of the genus Hypericum.
- the plant extract of the genus Pteridium is derived from Pteridium aquilifolium, Pteridium aquiliformis or Pteridium aquilinum and the plant extract of the genus Hypericum is derived from Hypericum perforatum or of Hypericum androseanum.
- a concentrated composition according to the preferred invention comprises extracts of Hex aquifolium, Pteridium aquilinum and Hypericum perforatum.
- Another preferred concentrated composition according to the invention comprises extracts of Hex aquifolium, Pteridium aquilinum and Hypericum androseanum.
- the concentrated composition according to the invention comprises
- the concentrated composition according to the invention comprises
- the concentrated composition according to the invention may also comprise a support chosen from o thick paraffin oils or paraffin oils having a density at 20 ° C of between 0.860 and 0.890 g / ml and a viscosity at 20 ° C of between 100 mPa.s and 250 mPa.s or oils paraffin wax having a density at 20 ° C of 0.862 to 0.875 g / ml and a viscosity at 20 ° C of 140 mPa.s to 185 mPa.s;
- R represents a group CC 20 alkyl, preferably a C 8 group - C15 alkyl, in particular a group Ci 3 alkyl, preferably an n-tridecanyl;
- R 2 represents a CC pack 20 alkyl, preferably a group Ci - This alkyl, especially a C 3 alkyl, preferably an isopropyl group;
- one or other of these supports and an alcohol chosen from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol;
- an alcohol chosen from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol.
- the invention also relates to processes for preparing a concentrated composition according to the invention.
- the processes for preparing the concentrated composition according to the invention comprise grinding the leaves of plants used.
- the grinding is carried out with fresh leaves, in particular to make it possible to increase the quantities of substances extracted.
- the preparation process can also be carried out by grinding frozen leaves. Freezing or freezing, especially under conditions limiting or preventing any evaporation of the substances to be extracted, then makes it possible to preserve the leaves between their harvest and the preparation of the concentrated composition according to the invention.
- the plants useful for carrying out the processes for preparing the concentrated composition according to the invention are the plants included in this composition.
- the preparation methods according to the invention are implemented from an extract of a plant of the genus Ilex.
- the plant extract is derived from a plant selected from Ilex aquifolium, Ilex aquiliformis, Ilex guayusa, Ilex paraguariensis, Ilex vomitoria, or is derived from a plant selected from Ilex aquifolium, Ilex aquiliformis, Ilex
- Ilex vomitoria preferably it is an extract of Ilex aquifolium.
- the processes for preparing a concentrated composition according to the invention also use at least one extract of a plant of the genus Pteridium, in particular Pteridium aquilifolium, Pteridium aquiliformis or Pteridium aquilinum, or at least one extract of a plant of the genus Hypericum, in particular
- the processes for preparing a concentrated composition according to the invention also use at least one extract of a plant of the genus Pteridium and at least one extract of a plant of the genus Hypericum.
- the invention provides a method (P1) for preparing a concentrated composition comprising
- R represents a group CC 20 alkyl, preferably a C 8 group - C15 alkyl, in particular a group Ci 3 alkyl, preferably an n-tridecanyl;
- R 2 represents a CC pack 20 alkyl, preferably a group Ci - This alkyl, especially a C 3 alkyl, preferably an isopropyl group;
- one or other of these supports and an alcohol chosen from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol;
- an alcohol chosen from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol;
- the crushing of the sheets is also carried out in the maceration support.
- this process (P1) combines totally or partially the following characteristics:
- the grinding is carried out within three days following the harvest of the leaves or is carried out for a period ranging from 5 to 45 min or is carried out for a period ranging from 10 to 25 min;
- decantation is carried out for a period ranging from 30 minutes to 24 hours or is carried out for a period ranging from 4 to 8 hours.
- this method (P1) combines the following characteristics:
- the maceration is carried out for a period ranging from 6 to 36 hours;
- decantation is carried out for a period ranging from 30 minutes to 24 hours.
- this method (P1) combines the following characteristics:
- the grinding is carried out within three days following the harvest of the leaves and for a duration ranging from 10 to 25 min;
- decantation is carried out for a period ranging from 4 to 8 hours.
- the preparation method (P1) can also combine the grinding of the leaves and the stirring.
- the invention also provides a process (P2) for preparing a concentrated composition comprising
- the grinding of the sheets is also carried out in the alcohol.
- this process (P2) according to the invention completely or partially combines the following characteristics: • the grinding is carried out within three days following the harvest of the leaves or is carried out for a period ranging from 5 to 45 min or is carried out for a period ranging from 10 to 25 min;
- Heating is carried out at the reflux temperature of the alcohol or is carried out for a period ranging from 5 to 45 min or from 10 to 30 min, for example a duration of 15 min;
- Centrifugation of the heating product is carried out for 10 min or 5000 rpm;
- this process (P2) combines the following characteristics:
- Heating is carried out at the reflux temperature of the alcohol and for a period ranging from 5 to 45 min;
- Centrifugation of the heating product is carried out for 10 minutes and at 5000 rpm;
- this process (P2) combines the following characteristics:
- the grinding is carried out within three days following the harvest of the leaves and for a duration ranging from 10 to 25 min;
- Heating is carried out at the reflux temperature of the alcohol and for a period ranging from 10 to 30 min, for example a duration of 15 min;
- Centrifugation of the heating product is carried out for 10 minutes and at 5000 rpm;
- the process (P2) can also combine the crushing of the sheets with the agitation of the medium.
- the present invention also relates to a formulation comprising a concentrated composition according to the invention combined with an oily type support.
- the invention also provides a formulation comprising a concentrated composition according to the invention combined with isopropyl myristate (propan-2-yl tetradecanoate) or glycerol (propane-1,2,3-triol).
- the formulation according to the invention preferably comprises a support chosen from light paraffin oils or paraffin oils whose density at 20 ° C is between 0.845 and 0.855 g / fnl and whose viscosity at 20 ° C is between 10 mPa.s and 90 mPa.s or paraffin oils whose density at 20 ° C is between 0.850 and 0.853 g / ml and whose viscosity at 20 ° C is between 25 mPa. s and 35 mPa.s.
- the formulation according to the invention may also comprise a surfactant or emollient or propylene glycol diester of fatty acids of plant origin, saturated and chain lengths of C 8 -C 0.
- the formulation according to the invention comprises from 5 to 30% of concentrated composition according to the invention and from 70 to 95% of support.
- the formulation according to the invention comprises from 5 to 30% of concentrated composition according to the invention and from 70 to 95% of support and an emollient or propylene glycol diester of fatty acids of origin vegetable, saturated and with chain lengths in C 8 -Ci 0 .
- the formulation according to the invention comprises 10% of concentrated composition according to the invention and 90% of support or 90% of support and an emollient or propylene glycol diester of original fatty acids. vegetable, saturated and with chain lengths in C 8 -Ci 0 .
- the formulation according to the invention may comprise the different variants of the concentrated composition according to the invention. It may therefore comprise an extract of a plant of the genus Ex or an extract of a plant of the genus ex, excluding a fruit extract.
- the plant extract is derived from a plant selected from ex aquifolium, ex aquiliformis, ex guayusa, ex paraguariensis, ex vomitoria, preferably it is an extract of ex aquifolium.
- the formulation according to the invention also comprises at least one extract of a plant of the genus Pteridium, in particular of Pteridium aquilifolium, Pteridium aquiliformis or Pteridium aquilinum, or at least one extract of a plant of the genus Hypericum, in particular Hypericum androseanum or Hypericum perforatum. More preferably, the formulation according to the invention also comprises at least one extract of a plant of the genus Pteridium and at least one extract of a plant of the genus Hypericum.
- the formulation according to the invention comprises extracts of Ilex aquifolium, Pteridium aquilinum and Hypericum perforatum.
- the formulation according to the invention comprises extracts of Ilex aquifolium, Pteridium aquilinum and Hypericum androseanum.
- the respective proportions of concentrated composition and support can vary quite widely. However, very good results can be obtained during the implementation of the formulation according to the invention for which the mass ratio composition / support ranges from 2/98 to 15/85 or ranges from 5/95 to 12/88. or is equal to 10/90.
- the invention also relates to a process for preparing a formulation according to the invention comprising
- the composition / support mass ratio is generally from 2/98 to 15/85 or preferably from 5/95 to 12/88 or is equal to at 10/90.
- the concentrated composition and the formulation according to the invention can be used for the treatment of numerous conditions, in particular dermatological conditions, or for their soothing or cleansing properties of the epidermis of animals, including farm animals.
- composition and the formulation according to the invention can also be used to improve the skin's suppleness, to calm the irritation, to promote healing, to eliminate the dander and to accelerate the regrowth of the hair, in particular of farm animals.
- the invention also relates to a concentrated composition according to the invention or a formulation according to the invention for its use to fight against mycosis or human or animal dermatoses or to fight against fungal infections or dermatoses, in particular mycozoonoses, cattle, equines, sheep, goats, pigs, poultry, rodents, insectivores, birds, rabbits, dogs, cats or to control Trichophyton including Trichophyton equinum, Trichophyton erinacei, Trichophyton Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton ochraceum, Trichophyton quinckeanum Trichophyton rubrum; Microsporum including Microsporum audouini, Microsporum
- the invention also relates to a method of treatment for combating mycosis or human or animal dermatoses or for combating fungal infections or dermatoses, in particular mycozoonoses, cattle, equines, sheep, sheep and goats.
- Trichophyton including Trichophyton equinum, Trichophyton erinacei, Trichophyton gallinae, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton ochraceum, Trichophyton quinckeanum Trichophyton rubrum; Microsporum including Microsporum audouini, Microsporum
- the method according to the invention comprises the application made by spraying a formulation according to the invention or by the spray application of a concentrated composition according to the invention.
- Example 1 Composition (CD according to the invention
- composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium, Pteridium aquilinum and Hypericum androseanum set
- Example 2 Composition (C2) According to the Invention
- composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium, Pteridium aquilinum and Hypericum androseanum:
- a 200 ml flask is made up with ethanol (qs).
- Example 3 Composition (C3) According to the Invention It is a composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium, Pteridium aquilinum and Hypericum androseanum macerated in oil and ethanol: 15 grams of leaves fresh Hex aquifolium, 2 grams of fresh leaves of Pteridium aquilinum and 2 grams of fresh leaves of Hypericum androseanum are milled for 15 minutes in 600ml of paraffin oil (Cooper of Exxon Mobil, density at 20 ° C: Q865g / ml and viscosity at 20 ° C: 176 mPa.s) to which 3% by weight of ethanol is added. After maceration for 24 hours and decantation for 3 hours, the supernatant is filtered.
- paraffin oil Cooper of Exxon Mobil, density at 20 ° C: Q865g / ml and viscosity at 20 ° C: 176 mPa.s
- Example 4 Composition (C4) According to the Invention
- composition comprising plant extracts obtained from fresh leaves of Hex aquifolium. 15 g of leaves are crushed for 15 min in 600 ml of paraffin oil (density at 20 ° C: 0.865 g / ml and viscosity at 20 ° C: 176 mPa.s) then macerated for 24 hours before settling during 3 hours. The supernatant is then filtered and makes it possible to obtain 500 ml of concentrated composition (C4) according to the invention.
- Example 5 Composition (C5) According to the Invention
- Example 6 Composition (C6) According to the Invention
- composition comprising plant extracts obtained from fresh leaves of Hex aquifolium macerated in oil and ethanol: 15 grams of fresh leaves of Hex aquifolium are milled for 15 minutes. minutes in 600 ml of paraffin oil (Cooper Exxon Mobil, density at 20 ° C: Q865g / ml and viscosity at 20 ° C: 176 mPa.s) to which is added 3% by weight of ethanol. After maceration for 24 hours and decantation for 3 hours, the supernatant is filtered. 500 ml of a concentrated composition (C6) according to the invention are obtained.
- composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium, Pteridium aquilinum and Hypericum androseanum macerated in an ester: 15 grams of fresh leaves of Ilex aquifolium, 2 grams of fresh leaves of Pteridium aquilinum and 2 grams of fresh leaves of Hypericum androseanum are milled for 15 minutes in 600ml of isopropyl myristate (Product Aroma Zone, France). After maceration for 24 hours and decantation for 3 hours, the supernatant is filtered.
- Example 8 Composition (C8) According to the Invention
- This is a composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium, Pteridium aquilinum and Hypericum androseanum macerated in an ester and ethanol: 15 grams of fresh leaves of Ilex aquifolium, 2 grams of fresh leaves of Pteridium aquilinum and 2 grams of fresh leaves of Hypericum androseanum are milled for 15 minutes in 600ml of isopropyl myristate (Product Aroma Zone, France), to which is added 3% by weight ethanol. After maceration for 24 hours and decantation for 3 hours, the supernatant is filtered.
- Example 9 Composition (C9) According to the Invention
- This is a composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium. 15 g of leaves are crushed for 15 min in 600 ml of isopropyl myristate (Product Aroma Zone, France) then macerated for 24 hours before settling for 3 hours. The supernatant is then filtered and makes it possible to obtain 500 ml of concentrated composition (C9) according to the invention.
- Example 10 Composition (C10) According to the Invention
- composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium macerated in an ester and ethanol: 15 grams of Fresh leaves of Hex aquifolium are milled for 15 minutes in 600 ml of isopropyl myristate (Product Aroma Zone, France) to which 3% by weight of ethanol is added. After maceration for 24 hours and decantation for 3 hours, the supernatant is filtered.
- Example 1 1 Formulation (F1) According to the Invention
- Example 1 The concentrated composition obtained in Example 1 (500 ml) is diluted in light paraffin oil (Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s ) until you obtain 5 liters of formula (F1) ready for use.
- light paraffin oil Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s
- Example 2 The concentrated composition obtained in Example 2 (200 ml) is diluted in light paraffin oil (Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s) until you obtain 5 liters of formulation (F2) ready for use.
- light paraffin oil Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s
- Example 3 The concentrated composition obtained in Example 3 (500 ml) is diluted in light paraffin oil (Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s) until you obtain 5 liters of formulation (F3) ready for use.
- light paraffin oil Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s
- Example 5 The concentrated composition obtained in Example 5 (200 ml) is diluted in light paraffin oil (Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s) until you obtain 5 liters of formulation (F4) ready for use. An emulsifying agent is added until a homogeneous and stable mixture is obtained.
- light paraffin oil Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s
- Example 6 The concentrated composition obtained in Example 6 (500 ml) is diluted in light paraffin oil (Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s) until you obtain 5 liters of formulation (F5) ready for use.
- light paraffin oil Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s
- Example 16 Formulation (F6) According to the Invention Of the concentrated composition obtained in Example 1 (500 ml) and 250 ml of Mygliol 840 (propylene glycol diester of vegetable fatty acids, saturated and with chain lengths C 8 -Ci 0 whose viscosity at 20 ° C is between 9 and 12 mPa.s) are diluted in light paraffin oil (density at 20 ° C: 0.852g / ml and viscosity at 20 ° C: 29 mPa.s) to obtain 5 liters formulation formulation (F6) ready for use.
- Light paraffin oil density at 20 ° C: 0.852g / ml and viscosity at 20 ° C: 29 mPa.s
- Example 4 The concentrated composition obtained in Example 4 (500 ml) is diluted in paraffin oil (density at 20 ° C: 0.865 g / ml and viscosity at 20 ° C: 176 mPa.s) to obtain 5 liters of formulation (F7) ready for use.
- paraffin oil density at 20 ° C: 0.865 g / ml and viscosity at 20 ° C: 176 mPa.s
- Example 9 The concentrated composition obtained in Example 9 (500 ml) is diluted in light paraffin oil (Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s) to obtain 5 liters of formulation (F8) ready for use.
- light paraffin oil Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s
- the cows have round-shaped plates characteristic of ringworm (Trichophyon verrucosum).
- the ringlets are covered with the formulation.
- the treatment is renewed three days after the first application.
- the formulation eliminates all the ringworm plates.
- Example 20 Efficacy against ringworm affecting a person
- the groomer presents on the forearm round-shaped plates characteristic of ringworm (Microsporum canis).
- the ringlets are covered with the formulation.
- the treatment is renewed three days after the first application.
- the formulation causes no skin reaction and eliminates all ringworm. No plaque is visible one week after the start of treatment.
- the five treated horses have problems with mud mange (Dermatitis verrucosa with Cladosporium or Phialophora, dermatophilosis with Dermatophilus congolensis) and ringworm (Trichophyton equinus).
- the formulation thus makes it possible to rapidly eliminate all the traces of mud mange as well as the ring-worm plates.
- a first batch of 10 cattle was treated with a formulation (F1) according to Example 1 1
- a second batch of 10 cattle was treated with a formulation (F2) according to Example 12
- a batch of 10 cattle was treated with a veterinary reference product.
- This veterinary reference product for the treatment of Trichophyton verrucosum comprises enilconazole (Imaveral commercial product) and has been used according to the recommended conditions.
- the treatments were carried out by spraying the animals (on the lesions and on an area of 3 cm around the lesions).
- Formulations (F1) and (F2) were applied twice 4 days apart.
- a score of 0 corresponds to an absence of a visual sign of impairment
- a score of 1 corresponds to a weak impairment
- a score of 2 corresponds to a moderate impairment
- a score of 3 corresponds to a severe impairment (alopecia).
- the score awarded corresponds to an overall score of the three criteria.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention concerns the use of plant extracts or mixtures of plant extracts, in particular an extract of a plant of the ilex genus, preferably an extract of ilex aquifolium. These plant extracts or mixtures of plant extracts are particularly advantageous for the treatment of conditions, in particular dermatological conditions, or indeed for the properties of same with regard to soothing or cleansing the skin of animals, in particular livestock. The invention also concerns a concentrated composition and a formulation suitable for these uses.
Description
COMPOSITION D'EXTRAITS Ό' ILEX AQUIFOLIUM ET SON UTILISATION ILEX AQUIFOLIUM EXTRACT COMPOSITION AND USE THEREOF
DESCRIPTION DESCRIPTION
5 La présente invention concerne l'utilisation d'extraits de plantes ou de mélanges d'extraits de plantes, en particulier un extrait d'une plante du genre //ex, de préférence un extrait d'//ex aquifolium. Ces extraits de plantes ou de mélanges d'extraits de plantes sont particulièrement avantageux pour le traitement d'affections, notamment d'affections dermatologiques, ou encore pour leurs propriétés apaisantes ou nettoyantes de î o l'épiderme des animaux, notamment des animaux d'élevage. L'invention concerne également une composition concentrée et une formulation adaptées à ces utilisations. The present invention relates to the use of plant extracts or mixtures of plant extracts, in particular an extract of a plant of the genus // ex, preferably an extract of // ex aquifolium. These plant extracts or plant extract mixtures are particularly advantageous for the treatment of diseases, especially dermatological conditions, or for their soothing or cleansing properties of the epidermis of animals, especially animals of breeding. The invention also relates to a concentrated composition and a formulation adapted to these uses.
On connaît certaines plantes pour leurs propriétés particulières, notamment pour leurs qualités vulnéraires ou résolutives, par exemple pour des propriétés anesthésiante,Some plants are known for their particular properties, especially for their vulnerable or resolving qualities, for example for anesthetic properties,
15 calmante, cicatrisante, désinfectante ou émolliente. Soothing, healing, disinfecting or emollient.
Par exemple, Sahayaraj et al. ont décrit l'utilisation d'extraits de Pteridium aquilinum obtenus par action du chloroforme, pour la lutte contre la rouille et la septoriose de plants d'arachides (Sahayaraj et al., Antifungal activity of three fern extracts on causative agents of groundnut early leaf spot and rust diseases, 2009). For example, Sahayaraj et al. have described the use of Pteridium aquilinum extracts obtained by the action of chloroform, for the fight against rust and septoria of peanut plants (Sahayaraj et al., Antifungal activity of three fern extracts on causative agents of groundnut early leaf spot and rust diseases, 2009).
20 WO-2005/063266 concerne une composition dermatologique comprenant des extraits d'Hypericum perforatum et de Calendula officinalis. Le traitement plus spécifique du psoriasis est visé. WO-2005/063266 relates to a dermatological composition comprising extracts of Hypericum perforatum and Calendula officinalis. The more specific treatment of psoriasis is aimed at.
Par ailleurs, Erdemoglu et al. ont décrit le criblage d'extraits de feuilles sèches d'//ex aquifolium (Erdemoglu et al., Antibacterial, antifungal and antimycobacterial activity of llex 25 acquifolium, 2009). In addition, Erdemoglu et al. described the screening of extracts of dry leaves of ex-aquifolium (Erdemoglu et al., Antibacterial, antifungal and antimycobacterial activity of llexacifolium, 2009).
Toutefois, ces plantes ne sont pas souvent utilisées de manière efficace pour le traitement d'affections dermatologiques, notamment du fait de difficultés pour sélectionner ces plantes. However, these plants are not often used effectively for the treatment of dermatological conditions, particularly because of difficulties in selecting these plants.
Une autre difficulté concerne le choix des plantes à associer les unes avec les autres afin 30 d'en améliorer les propriétés. Another difficulty relates to the choice of the plants to be associated with each other in order to improve the properties thereof.
D'autres difficultés concernent les méthodes de préparations d'extraits de plantes ainsi que leur utilisation au sein de compositions concentrées ou de formulations utilisables directement lors de l'application.
D'autres difficultés connues dans le domaine des traitements à base d'extraits de plantes sont la nécessité de passer par une étape de dilution préalablement à leur application, notamment sur des animaux ou en des lieux d'élevage d'animaux. Other difficulties relate to methods for preparing plant extracts and their use in concentrated compositions or formulations that can be used directly during application. Other known difficulties in the field of treatments based on plant extracts are the need to go through a dilution step prior to their application, especially on animals or animal breeding sites.
Par ailleurs, on connaît un inconvénient ou un risque lors de l'utilisation d'extraits de 5 plantes qui concerne leur toxicité qui peut s'avérer rédhibitoire à leur utilisation simple et efficace. Furthermore, there is a disadvantage or a risk when using extracts of 5 plants which concerns their toxicity which may be prohibitive to their simple and effective use.
Ainsi, la présente invention permet d'apporter une solution à tout ou partie de ces problèmes. Thus, the present invention provides a solution to all or part of these problems.
î o D'autres avantages de l'invention apparaîtront lors de sa description détaillée, notamment par les exemples de mises en œuvre de cette invention. Other advantages of the invention will become apparent in its detailed description, in particular by the examples of implementations of this invention.
La présente invention concerne donc une composition concentrée comprenant au moins un extrait d'une plante du genre llex en une concentration allant de 5 à 80 g/1. The present invention therefore relates to a concentrated composition comprising at least one extract of a plant of the genus llex in a concentration ranging from 5 to 80 g / l.
15 15
La présente invention concerne également une composition concentrée comprenant au moins un extrait d'une plante du genre llex en une concentration allant de 5 à 80 g/1, à l'exclusion d'un extrait de fruits d'une plante du genre llex. The present invention also relates to a concentrated composition comprising at least one extract of a plant of the genus llex in a concentration ranging from 5 to 80 g / l, excluding a fruit extract of a plant of the genus llex.
20 De manière préférée, la composition concentrée selon l'invention comprend au moins un extrait de feuilles fraîches ou de feuilles fraîches surgelées d'une plante du genre llex en une concentration allant de 5 à 80 g/1. Preferably, the concentrated composition according to the invention comprises at least one extract of fresh leaves or fresh frozen leaves of a plant of the genus llex in a concentration ranging from 5 to 80 g / l.
De manière avantageuse, l'extrait de plante au sein de la composition selon l'invention 25 est issu d'une plante choisie parmi llex aquifolium, llex aquiliformis, llex guayusa, llex paraguariensis, llex vomitoria, ou bien issu d'une plante choisie parmi llex aquifolium, llex aquiliformis, llex guayusa, llex vomitoria, de préférence il s'agit d'un extrait d'Hex aquifolium. Advantageously, the plant extract within the composition according to the invention is derived from a plant selected from llex aquifolium, llex aquiliformis, llex guayusa, llex paraguariensis, llex vomitoria, or from a selected plant. among llex aquifolium, llex aquiliformis, llex guayusa, llex vomitoria, preferably it is an extract of Hex aquifolium.
30 Au sein de la composition selon l'invention, la concentration en extrait de plante du genre llex peut aller de 15 à 60 g/l ou de 25 à 45 g/l. De manière avantageuse, elle peut être de
De manière préférée, la composition concentrée selon l'invention comprend également au moins un extrait d'une plante du genre Pteridium ou au moins un extrait d'une plante du genre Hypericum. De manière plus préférée, la composition concentrée selon l'invention comprend également au moins un extrait d'une plante du genre Pteridium et au moins un 5 extrait d'une plante du genre Hypericum. Within the composition according to the invention, the concentration of llex plant extract can range from 15 to 60 g / l or from 25 to 45 g / l. Advantageously, it can be Preferably, the concentrated composition according to the invention also comprises at least one extract of a plant of the genus Pteridium or at least one extract of a plant of the genus Hypericum. More preferably, the concentrated composition according to the invention also comprises at least one extract of a plant of the genus Pteridium and at least one extract of a plant of the genus Hypericum.
De manière particulièrement avantageuses, au sein de la composition selon l'invention, l'extrait de plante du genre Pteridium est issu de Pteridium aquilifolium, Pteridium aquiliformis ou Pteridium aquilinum et l'extrait de plante du genre Hypericum est issu d'Hypericum perforatum ou d'Hypericum androseanum. Particularly advantageously, within the composition according to the invention, the plant extract of the genus Pteridium is derived from Pteridium aquilifolium, Pteridium aquiliformis or Pteridium aquilinum and the plant extract of the genus Hypericum is derived from Hypericum perforatum or of Hypericum androseanum.
î o Une composition concentrée selon l'invention préférée comprend des extraits d'Hex aquifolium, de Pteridium aquilinum et d'Hypericum perforatum. A concentrated composition according to the preferred invention comprises extracts of Hex aquifolium, Pteridium aquilinum and Hypericum perforatum.
Une autre composition concentrée préférée selon l'invention comprend des extraits d'Hex aquifolium, de Pteridium aquilinum et d'Hypericum androseanum. Another preferred concentrated composition according to the invention comprises extracts of Hex aquifolium, Pteridium aquilinum and Hypericum androseanum.
15 De manière avantageuse, la composition concentrée selon l'invention comprend Advantageously, the concentrated composition according to the invention comprises
• un extrait d'une plante du genre //ex en une concentration allant de 5 à 80 g/1 ou de 15 à 60 g/l ou de 25 à 45 g/l ou bien de 30 g/l ; An extract of a plant of the genus ex in a concentration ranging from 5 to 80 g / l or from 15 to 60 g / l or from 25 to 45 g / l or even 30 g / l;
• un extrait de plante du genre Pteridium en une concentration allant de 1 à 30 g/l ou allant de 2 à 20 g/l ou allant de 3 à 10 g/l ou bien de 4 g/l et A plant extract of the genus Pteridium in a concentration ranging from 1 to 30 g / l or ranging from 2 to 20 g / l or ranging from 3 to 10 g / l or even 4 g / l and
20 « un extrait de plante du genre Hypericum en une concentration allant de 1 à 30 g/l ou allant de 2 à 20 g/l ou allant de 3 à 10 g/l ou bien de 4 g/l. "A plant extract of the genus Hypericum in a concentration of from 1 to 30 g / l or from 2 to 20 g / l or from 3 to 10 g / l or of 4 g / l.
De manière particulièrement avantageuse, la composition concentrée selon l'invention comprend In a particularly advantageous manner, the concentrated composition according to the invention comprises
• un extrait d'//ex aquifolium en une concentration allant de 25 à 45 g/l ; An extract of ex aquifolium in a concentration ranging from 25 to 45 g / l;
25 · un extrait de Pteridium aquilinum en une concentration allant de 3 à 10 g/l ; An extract of Pteridium aquilinum in a concentration of from 3 to 10 g / l;
• un extrait d'Hypericum perforatum en une concentration allant de 3 à 10 g/l ; ou encore • an extract of Hypericum perforatum in a concentration ranging from 3 to 10 g / l; or
• un extrait d'//ex aquifolium en une concentration allant de 25 à 45 g/l ; An extract of ex aquifolium in a concentration ranging from 25 to 45 g / l;
• un extrait de Pteridium aquilinum en une concentration allant de 3 à 10 g/l ; • an extract of Pteridium aquilinum in a concentration ranging from 3 to 10 g / l;
30 « un extrait d'Hypericum androseanum en une concentration allant de 3 à 10 g/l. "An extract of Hypericum androseanum in a concentration ranging from 3 to 10 g / l.
La composition concentrée selon l'invention peut également comprendre un support choisi parmi
o les huiles de paraffine épaisses ou les huiles de paraffine dont la densité à 20°C est comprise entre 0,860 et 0,890 g/ml et dont la viscosité à 20 °C est comprise entre 100 mPa.s et 250 mPa.s ou les huiles de paraffine dont la densité à 20 °C est comprise entre 0,862 et 0,875 g/fml et dont la viscosité à 20°C est comprise entre 140 mPa.s et 185 mPa.s ; The concentrated composition according to the invention may also comprise a support chosen from o thick paraffin oils or paraffin oils having a density at 20 ° C of between 0.860 and 0.890 g / ml and a viscosity at 20 ° C of between 100 mPa.s and 250 mPa.s or oils paraffin wax having a density at 20 ° C of 0.862 to 0.875 g / ml and a viscosity at 20 ° C of 140 mPa.s to 185 mPa.s;
o les huiles de paraffine légères ou les huiles de paraffine dont la densité à 20 °C est comprise entre 0,810 et 0,855 g/ml et dont la viscosité à 20 °C est comprise entre 10 mPa.s et 90 mPa.s ou les huiles de paraffine dont la densité à 20°C est comprise entre 0,850 et 0,853 g/ml et dont la viscosité à 20 °C est comprise entre 25 mPa.s et 35 mPa.s ; light paraffin oils or paraffin oils whose density at 20 ° C is between 0.810 and 0.855 g / ml and whose viscosity at 20 ° C is between 10 mPa.s and 90 mPa.s or oils paraffin whose density at 20 ° C is between 0.850 and 0.853 g / ml and whose viscosity at 20 ° C is between 25 mPa.s and 35 mPa.s;
o les composés de formule (I) the compounds of formula (I)
dans laquelle in which
R représente un groupement C C20 alkyl, de préférence un groupement C8- C15 alkyl, en particulier un groupement Ci3 alkyl, de préférence un groupement n-tridecanyl ; R represents a group CC 20 alkyl, preferably a C 8 group - C15 alkyl, in particular a group Ci 3 alkyl, preferably an n-tridecanyl;
R2 représente un groupement C C20 alkyl, de préférence un groupement Ci - Ce alkyl, en particulier un groupement C3 alkyl, de préférence un groupement isopropyl ; R 2 represents a CC pack 20 alkyl, preferably a group Ci - This alkyl, especially a C 3 alkyl, preferably an isopropyl group;
en particulier le myristate d'isopropyle ou tétradécanoate de propan-2-yle ; o le glycerol ou propane-1 ,2,3-triol ; in particular isopropyl myristate or propan-2-yl tetradecanoate; glycerol or propane-1,2,3-triol;
o l'un ou l'autre de ces supports et un alcool choisi parmi le méthanol, l'éthanol, le n-propanol, l'isopropanol, le n-butanol et l'isobutanol, de préférence l'éthanol ; one or other of these supports and an alcohol chosen from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol;
o un alcool choisi parmi le méthanol, l'éthanol, le n-propanol, l'isopropanol, le n- butanol et l'isobutanol, de préférence l'éthanol. an alcohol chosen from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol.
L'invention concerne également des procédés de préparation d'une composition concentrée selon l'invention. The invention also relates to processes for preparing a concentrated composition according to the invention.
Les procédés de préparation de la composition concentrée selon l'invention comprennent
le broyage des feuilles de plantes utilisées. De manière préférée, le broyage est effectué avec des feuilles fraîches, en particulier pour permettre d'augmenter les quantités de substances extraites. Toutefois, le procédé de préparation peut également être mis en œuvre en broyant des feuilles surgelées. La surgélation ou congélation, notamment dans 5 des conditions limitant ou empêchant toute évaporation des substances à extraire, permet alors de préserver les feuilles entre leur récolte et la préparation de la composition concentrée selon l'invention. The processes for preparing the concentrated composition according to the invention comprise grinding the leaves of plants used. Preferably, the grinding is carried out with fresh leaves, in particular to make it possible to increase the quantities of substances extracted. However, the preparation process can also be carried out by grinding frozen leaves. Freezing or freezing, especially under conditions limiting or preventing any evaporation of the substances to be extracted, then makes it possible to preserve the leaves between their harvest and the preparation of the concentrated composition according to the invention.
Les plantes utiles à la mise en œuvre des procédés de préparation de la composition î o concentrée selon l'invention sont les plantes comprises dans cette composition. The plants useful for carrying out the processes for preparing the concentrated composition according to the invention are the plants included in this composition.
Ainsi, les procédés de préparation selon l'invention sont mis en œuvre à partir d'un extrait d'une plante du genre Ilex. De manière avantageuse, l'extrait de plante est issu d'une plante choisie parmi Ilex aquifolium, Ilex aquiliformis, Ilex guayusa, Ilex paraguariensis, Ilex vomitoria, ou est issu d'une plante choisie parmi Ilex aquifolium, Ilex aquiliformis, Ilex Thus, the preparation methods according to the invention are implemented from an extract of a plant of the genus Ilex. Advantageously, the plant extract is derived from a plant selected from Ilex aquifolium, Ilex aquiliformis, Ilex guayusa, Ilex paraguariensis, Ilex vomitoria, or is derived from a plant selected from Ilex aquifolium, Ilex aquiliformis, Ilex
15 guayusa, Ilex vomitoria, de préférence il s'agit d'un extrait d'Ilex aquifolium. Guayusa, Ilex vomitoria, preferably it is an extract of Ilex aquifolium.
De manière préférée, les procédés de préparation d'une composition concentrée selon l'invention mettent également en œuvre au moins un extrait d'une plante du genre Pteridium, en particulier de Pteridium aquilifolium, Pteridium aquiliformis ou Pteridium aquilinum, ou au moins un extrait d'une plante du genre Hypericum, en particulier Preferably, the processes for preparing a concentrated composition according to the invention also use at least one extract of a plant of the genus Pteridium, in particular Pteridium aquilifolium, Pteridium aquiliformis or Pteridium aquilinum, or at least one extract of a plant of the genus Hypericum, in particular
20 Hypericum androseanum ou Hypericum perforatum. Hypericum androseanum or Hypericum perforatum.
De manière plus préférée, les procédés de préparation d'une composition concentrée selon l'invention mettent également en œuvre au moins un extrait d'une plante du genre Pteridium et au moins un extrait d'une plante du genre Hypericum. More preferably, the processes for preparing a concentrated composition according to the invention also use at least one extract of a plant of the genus Pteridium and at least one extract of a plant of the genus Hypericum.
De manière toute préférée, ces procédés de préparation mettent en œuvre des extraits Most preferably, these preparation methods use extracts
25 d'Ilex aquifolium, de Pteridium aquilinum et d'Hypericum perforatum ou des extraits d'Ilex aquifolium, de Pteridium aquilinum et d'Hypericum androseanum. Ilex aquifolium, Pteridium aquilinum and Hypericum perforatum or extracts of Ilex aquifolium, Pteridium aquilinum and Hypericum androseanum.
Ainsi, l'invention fournit un procédé (P1 ) de préparation d'une composition concentrée comprenant Thus, the invention provides a method (P1) for preparing a concentrated composition comprising
30 « le broyage de feuilles fraîches ou de feuilles fraîches surgelées d'au moins une plante définie pour la composition concentrée selon l'invention ; "Grinding fresh leaves or fresh frozen leaves of at least one plant defined for the concentrated composition of the invention;
• la macération du broyât dans un support choisi parmi
les huiles de paraffine épaisses ou les huiles de paraffine dont la densité à 20°C est comprise entre 0,860 et 0,890 g/ml et dont la viscosité à 20 °C est comprise entre 100 mPa.s et 250 mPa.s ou les huiles de paraffine dont la densité à 20 °C est comprise entre 0,862 et 0,875 g/fml et dont la viscosité à 20°C est comprise entre 140 mPa.s et 185 mPa.s ; • the maceration of the ground material in a support selected from paraffin oils or paraffin oils whose density at 20 ° C is between 0.860 and 0.890 g / ml and whose viscosity at 20 ° C is between 100 mPa.s and 250 mPa.s or the oils of paraffin whose density at 20 ° C is between 0.862 and 0.875 g / ml and whose viscosity at 20 ° C is between 140 mPa.s and 185 mPa.s;
les huiles de paraffine légères ou les huiles de paraffine dont la densité à 20 °C est comprise entre 0,810 et 0,855 g/ml et dont la viscosité à 20 °C est comprise entre 10 mPa.s et 90 mPa.s ou les huiles de paraffine dont la densité à 20°C est comprise entre 0,850 et 0,853 g/ml et dont la viscosité à 20 °C est comprise entre 25 mPa.s et 35 mPa.s ; light paraffinic oils or paraffin oils having a density at 20 ° C of between 0.810 and 0.855 g / ml and a viscosity at 20 ° C of between 10 mPa.s and 90 mPa.s or oils of paraffin whose density at 20 ° C is between 0.850 and 0.853 g / ml and whose viscosity at 20 ° C is between 25 mPa.s and 35 mPa.s;
(l) (L)
dans laquelle in which
R représente un groupement C C20 alkyl, de préférence un groupement C8- C15 alkyl, en particulier un groupement Ci3 alkyl, de préférence un groupement n-tridecanyl ; R represents a group CC 20 alkyl, preferably a C 8 group - C15 alkyl, in particular a group Ci 3 alkyl, preferably an n-tridecanyl;
R2 représente un groupement C C20 alkyl, de préférence un groupement Ci - Ce alkyl, en particulier un groupement C3 alkyl, de préférence un groupement isopropyl ; R 2 represents a CC pack 20 alkyl, preferably a group Ci - This alkyl, especially a C 3 alkyl, preferably an isopropyl group;
en particulier le myristate d'isopropyle ou tétradécanoate de propan-2-yle ; o le glycerol ou propane-1 ,2,3-triol ; in particular isopropyl myristate or propan-2-yl tetradecanoate; glycerol or propane-1,2,3-triol;
o l'un ou l'autre de ces supports et un alcool choisi parmi le méthanol, l'éthanol, le n-propanol, l'isopropanol, le n-butanol et l'isobutanol, de préférence l'éthanol ; one or other of these supports and an alcohol chosen from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol;
o un alcool choisi parmi le méthanol, l'éthanol, le n-propanol, l'isopropanol, le n- butanol et l'isobutanol, de préférence l'éthanol ; an alcohol chosen from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol;
• la décantation puis la filtration du produit de la macération. • the decantation then the filtration of the product of the maceration.
De manière avantageuse pour le procédé (P1 ) de préparation d'une composition concentrée selon l'invention, le broyage des feuilles est également réalisé dans le support de macération. Advantageously for the process (P1) for preparing a concentrated composition according to the invention, the crushing of the sheets is also carried out in the maceration support.
De manière également avantageuse, ce procédé (P1 ) selon l'invention combine
totalement ou partiellement les caractéristiques suivantes : Also advantageously, this process (P1) according to the invention combines totally or partially the following characteristics:
• le broyage est réalisé dans les trois jours suivants la récolte des feuilles ou est réalisé pendant une durée allant de 5 à 45 min ou est réalisé pendant une durée allant de 10 à 25 min ; • the grinding is carried out within three days following the harvest of the leaves or is carried out for a period ranging from 5 to 45 min or is carried out for a period ranging from 10 to 25 min;
• la macération est réalisée pendant une durée allant de 6 à 36 h ou est réalisée pendant une durée allant de 18 à 30 h ; • the maceration is carried out for a period ranging from 6 to 36 hours or is carried out for a period of 18 to 30 hours;
• la décantation est réalisée pendant une durée allant de 30 min à 24 h ou est réalisée pendant une durée allant de 4 à 8 h. • decantation is carried out for a period ranging from 30 minutes to 24 hours or is carried out for a period ranging from 4 to 8 hours.
De manière préférée, ce procédé (P1 ) combine les caractéristiques suivantes : In a preferred manner, this method (P1) combines the following characteristics:
• le broyage est réalisé dans les trois jours suivants la récolte des feuilles et pendant une durée allant de 5 à 45 min ; • the grinding is done within three days after the harvest of the leaves and for a period ranging from 5 to 45 min;
• la macération est réalisée pendant une durée allant de 6 à 36 h ; • The maceration is carried out for a period ranging from 6 to 36 hours;
• la décantation est réalisée pendant une durée allant de 30 min à 24 h. • decantation is carried out for a period ranging from 30 minutes to 24 hours.
De manière plus préférée, ce procédé (P1 ) combine les caractéristiques suivantes : More preferably, this method (P1) combines the following characteristics:
• le broyage est réalisé dans les trois jours suivants la récolte des feuilles et pendant une durée allant de 10 à 25 min ; • the grinding is carried out within three days following the harvest of the leaves and for a duration ranging from 10 to 25 min;
• la macération est réalisée pendant une durée allant de 18 à 30 h ; • the maceration is carried out for a period ranging from 18 to 30 hours;
• la décantation est réalisée pendant une durée allant de 4 à 8 h. • decantation is carried out for a period ranging from 4 to 8 hours.
De manière avantageuse, le procédé (P1 ), de préparation peut également combiner le broyage des feuilles et l'agitation. Advantageously, the preparation method (P1) can also combine the grinding of the leaves and the stirring.
L'invention fournit également un procédé (P2) de préparation d'une composition concentrée comprenant The invention also provides a process (P2) for preparing a concentrated composition comprising
• le broyage de feuilles fraîches ou de feuilles fraîches surgelées d'au moins une plante définie pour la composition concentrée selon l'invention ; Grinding fresh leaves or fresh frozen leaves of at least one plant defined for the concentrated composition according to the invention;
• le chauffage du broyât dans un alcool choisi parmi le méthanol, l'éthanol, le n- propanol, l'isopropanol, le n-butanol et l'isobutanol, de préférence l'éthanol ; • heating the ground material in an alcohol selected from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol;
• la centrifugation du produit de chauffage ; • centrifugation of the heating product;
• la séparation du surnageant. • the separation of the supernatant.
De manière avantageuse pour le procédé (P2) de préparation d'une composition concentrée selon l'invention, le broyage des feuilles est également réalisé dans l'alcool. De manière également avantageuse, ce procédé (P2) selon l'invention combine totalement ou partiellement les caractéristiques suivantes :
• le broyage est réalisé dans les trois jours suivants la récolte des feuilles ou est réalisé pendant une durée allant de 5 à 45 min ou est réalisé pendant une durée allant de 10 à 25 min ; Advantageously for the process (P2) for preparing a concentrated composition according to the invention, the grinding of the sheets is also carried out in the alcohol. Also advantageously, this process (P2) according to the invention completely or partially combines the following characteristics: • the grinding is carried out within three days following the harvest of the leaves or is carried out for a period ranging from 5 to 45 min or is carried out for a period ranging from 10 to 25 min;
• le chauffage est réalisé à la température de reflux de l'alcool ou est mis en œuvre pendant une durée allant de 5 à 45 min ou allant de 10 à 30 min, par exemple une durée de 15 min ; Heating is carried out at the reflux temperature of the alcohol or is carried out for a period ranging from 5 to 45 min or from 10 to 30 min, for example a duration of 15 min;
• la centrifugation du produit de chauffage est réalisée durant 10 min ou à 5 000 rpm ; Centrifugation of the heating product is carried out for 10 min or 5000 rpm;
• le surnageant séparé est conditionné. • the separated supernatant is conditioned.
De manière préférée, ce procédé (P2) combine les caractéristiques suivantes : In a preferred manner, this process (P2) combines the following characteristics:
• le broyage est réalisé dans les trois jours suivants la récolte des feuilles et pendant une durée allant de 5 à 45 min ; • the grinding is done within three days after the harvest of the leaves and for a period ranging from 5 to 45 min;
• le chauffage est réalisé à la température de reflux de l'alcool et pendant une durée allant de 5 à 45 min ; Heating is carried out at the reflux temperature of the alcohol and for a period ranging from 5 to 45 min;
• la centrifugation du produit de chauffage est réalisée durant 10 min et à 5 000 rpm ; Centrifugation of the heating product is carried out for 10 minutes and at 5000 rpm;
• le surnageant séparé est conditionné. • the separated supernatant is conditioned.
De manière plus préférée, ce procédé (P2) combine les caractéristiques suivantes : More preferably, this process (P2) combines the following characteristics:
• le broyage est réalisé dans les trois jours suivants la récolte des feuilles et pendant une durée allant de 10 à 25 min ; • the grinding is carried out within three days following the harvest of the leaves and for a duration ranging from 10 to 25 min;
• le chauffage est réalisé à la température de reflux de l'alcool et pendant une durée allant de 10 à 30 min, par exemple une durée de 15 min ; Heating is carried out at the reflux temperature of the alcohol and for a period ranging from 10 to 30 min, for example a duration of 15 min;
• la centrifugation du produit de chauffage est réalisée durant 10 min et à 5 000 rpm ; Centrifugation of the heating product is carried out for 10 minutes and at 5000 rpm;
• le surnageant séparé est conditionné. • the separated supernatant is conditioned.
De manière avantageuse, le procédé (P2) peut également combiner le broyage des feuilles avec l'agitation du milieu. Advantageously, the process (P2) can also combine the crushing of the sheets with the agitation of the medium.
La présente invention concerne également une formulation comprenant une composition concentrée selon l'invention combinée à support de type huileux. The present invention also relates to a formulation comprising a concentrated composition according to the invention combined with an oily type support.
L'invention fournit également une formulation comprenant une composition concentrée selon l'invention combinée à du myristate d'isopropyle (tétradécanoate de propan-2- yle) ou à du glycerol (propane-1 ,2,3-triol).
Comme support de type huileux, la formulation selon l'invention comprend de préférence un support choisi parmi les huiles de paraffine légères ou les huiles de paraffine dont la densité à 20 °C est comprise entre 0,845 et 0,855 g/fnl et dont la viscosité à 20 °C est comprise entre 10 mPa.s et 90 mPa.s ou les huiles de paraffine dont la densité à 20°C est comprise entre 0,850 et 0,853 g/ml et dont la viscosité à 20 °C est comprise entre 25 mPa.s et 35 mPa.s. The invention also provides a formulation comprising a concentrated composition according to the invention combined with isopropyl myristate (propan-2-yl tetradecanoate) or glycerol (propane-1,2,3-triol). As an oily support, the formulation according to the invention preferably comprises a support chosen from light paraffin oils or paraffin oils whose density at 20 ° C is between 0.845 and 0.855 g / fnl and whose viscosity at 20 ° C is between 10 mPa.s and 90 mPa.s or paraffin oils whose density at 20 ° C is between 0.850 and 0.853 g / ml and whose viscosity at 20 ° C is between 25 mPa. s and 35 mPa.s.
La formulation selon l'invention peut également comprendre un agent tensio-actif ou un agent émollient ou du propylène glycol diester d'acides gras d'origine végétale, saturés et à longueurs de chaînes en C8-Ci0. The formulation according to the invention may also comprise a surfactant or emollient or propylene glycol diester of fatty acids of plant origin, saturated and chain lengths of C 8 -C 0.
De manière avantageuse, la formulation selon l'invention comprend de 5 à 30% de composition concentrée selon l'invention et de 70 à 95% de support. Advantageously, the formulation according to the invention comprises from 5 to 30% of concentrated composition according to the invention and from 70 to 95% of support.
De manière également avantageuse, la formulation selon l'invention comprend de 5 à 30% de composition concentrée selon l'invention et de 70 à 95% de support et d'un agent émollient ou de propylène glycol diester d'acides gras d'origine végétale, saturés et à longueurs de chaînes en C8-Ci0. Also advantageously, the formulation according to the invention comprises from 5 to 30% of concentrated composition according to the invention and from 70 to 95% of support and an emollient or propylene glycol diester of fatty acids of origin vegetable, saturated and with chain lengths in C 8 -Ci 0 .
De manière particulièrement avantageuse, la formulation selon l'invention comprend 10% de composition concentrée selon l'invention et 90% de support ou bien 90% de support et d'un agent émollient ou de propylène glycol diester d'acides gras d'origine végétale, saturés et à longueurs de chaînes en C8-Ci0. Particularly advantageously, the formulation according to the invention comprises 10% of concentrated composition according to the invention and 90% of support or 90% of support and an emollient or propylene glycol diester of original fatty acids. vegetable, saturated and with chain lengths in C 8 -Ci 0 .
La formulation selon l'invention peut comprendre les différentes variantes de la composition concentrée selon l'invention. Elle peut donc comprendre un extrait d'une plante du genre //ex ou un extrait d'une plante du genre //ex à l'exclusion d'un extrait de fruits. De manière avantageuse, l'extrait de plante est issu d'une plante choisie parmi //ex aquifolium, //ex aquiliformis, //ex guayusa, //ex paraguariensis, //ex vomitoria, de préférence il s'agit d'un extrait d'//ex aquifolium. The formulation according to the invention may comprise the different variants of the concentrated composition according to the invention. It may therefore comprise an extract of a plant of the genus Ex or an extract of a plant of the genus ex, excluding a fruit extract. Advantageously, the plant extract is derived from a plant selected from ex aquifolium, ex aquiliformis, ex guayusa, ex paraguariensis, ex vomitoria, preferably it is an extract of ex aquifolium.
De manière préférée, la formulation selon l'invention comprend également au moins un extrait d'une plante du genre Pteridium, en particulier de Pteridium aquilifolium, Pteridium aquiliformis ou Pteridium aquilinum, ou au moins un extrait d'une plante du genre Hypericum, en particulier Hypericum androseanum ou Hypericum perforatum.
De manière plus préférée, la formulation selon l'invention comprend également au moins un extrait d'une plante du genre Pteridium et au moins un extrait d'une plante du genre Hypericum. Preferably, the formulation according to the invention also comprises at least one extract of a plant of the genus Pteridium, in particular of Pteridium aquilifolium, Pteridium aquiliformis or Pteridium aquilinum, or at least one extract of a plant of the genus Hypericum, in particular Hypericum androseanum or Hypericum perforatum. More preferably, the formulation according to the invention also comprises at least one extract of a plant of the genus Pteridium and at least one extract of a plant of the genus Hypericum.
De manière plus préférée, la formulation selon l'invention comprend des extraits d'Ilex aquifolium, de Pteridium aquilinum et d'Hypericum perforatum. More preferably, the formulation according to the invention comprises extracts of Ilex aquifolium, Pteridium aquilinum and Hypericum perforatum.
De manière également préférée, la formulation selon l'invention comprend des extraits d'Ilex aquifolium, de Pteridium aquilinum et d'Hypericum androseanum. Also preferably, the formulation according to the invention comprises extracts of Ilex aquifolium, Pteridium aquilinum and Hypericum androseanum.
Au sein de la formulation selon l'invention, les proportions respectives de composition concentrée et de support peuvent varier de manière assez large. Toutefois, de très bons résultats peuvent être obtenus lors de la mise en œuvre de la formulation selon l'invention pour laquelle le ratio en masse composition/support va de 2/98 à 15/85 ou va de 5/95 à 12/88 ou est égal à 10/90. Within the formulation according to the invention, the respective proportions of concentrated composition and support can vary quite widely. However, very good results can be obtained during the implementation of the formulation according to the invention for which the mass ratio composition / support ranges from 2/98 to 15/85 or ranges from 5/95 to 12/88. or is equal to 10/90.
L'invention concerne également un procédé de préparation d'une formulation selon l'invention comprenant The invention also relates to a process for preparing a formulation according to the invention comprising
• la préparation d'une composition concentrée selon l'invention, en particulier selon le procédé (P1 ) ou selon le procédé (P2) ; The preparation of a concentrated composition according to the invention, in particular according to the process (P1) or according to the process (P2);
• la dilution de la composition concentrée dans un support choisi parmi les huiles de paraffine légères ou les huiles de paraffine dont la densité à 20 °C est comprise entre 0,845 et 0,855 g/ml et dont la viscosité à 20 °C est comprise entre 10 mPa.s et 90 mPa.s ou les huiles de paraffine dont la densité à 20 °C est comprise entre 0,850 et 0,853 g/ml et dont la viscosité à 20 °C est comprise entre 25 mPa.s et 35 mPa.s ; le myristate d'isopropyle ou tétradécanoate de propan-2-yle ; le glycerol ou propane-1 ,2,3-triol. The dilution of the concentrated composition in a support chosen from light paraffin oils or paraffin oils whose density at 20 ° C. is between 0.845 and 0.855 g / ml and whose viscosity at 20 ° C. is between 10 ° C. and 10 ° C. mPa.s and 90 mPa.s or paraffin oils whose density at 20 ° C is between 0.850 and 0.853 g / ml and whose viscosity at 20 ° C is between 25 mPa.s and 35 mPa.s; isopropyl myristate or propan-2-yl tetradecanoate; glycerol or propane-1,2,3-triol.
Lors de la mise en œuvre du procédé de préparation d'une formulation selon l'invention, le ratio en masse composition/support va généralement de 2/98 à 15/85 ou de préférence de 5/95 à 12/88 ou est égal à 10/90. When carrying out the process for preparing a formulation according to the invention, the composition / support mass ratio is generally from 2/98 to 15/85 or preferably from 5/95 to 12/88 or is equal to at 10/90.
La composition concentrée et la formulation selon l'invention peuvent être utilisées pour le traitement de nombreuses affections, notamment d'affections dermatologiques, ou encore pour leurs propriétés apaisantes ou nettoyantes de l'épiderme des animaux,
notamment des animaux d'élevage. The concentrated composition and the formulation according to the invention can be used for the treatment of numerous conditions, in particular dermatological conditions, or for their soothing or cleansing properties of the epidermis of animals, including farm animals.
La composition et la formulation selon l'invention peuvent également être utilisées pour améliorer la souplesse cutanée, calmer l'irritation, favoriser la cicatrisation, éliminer les squames et accélérer la repousse du poil, notamment des animaux d'élevage. The composition and the formulation according to the invention can also be used to improve the skin's suppleness, to calm the irritation, to promote healing, to eliminate the dander and to accelerate the regrowth of the hair, in particular of farm animals.
5 5
Ainsi, l'invention concerne également une composition concentrée selon l'invention ou une formulation selon l'invention pour son utilisation pour lutter contre les mycoses ou les dermatoses humaines ou animales ou pour lutter contre les mycoses ou les dermatoses, en particulier les mycozoonoses, des bovins, des équidés, des ovins, des caprins, des î o porcins, des volailles, des rongeurs, des insectivores, des oiseaux, des lapins, des chiens, des chats ou pour lutter contre Trichophyton notamment Trichophyton equinum, Trichophyton erinacei, Trichophyton gallinae, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton ochraceum, Trichophyton quinckeanum Trichophyton rubrum ; Microsporum notamment Microsporum audouini, Microsporum Thus, the invention also relates to a concentrated composition according to the invention or a formulation according to the invention for its use to fight against mycosis or human or animal dermatoses or to fight against fungal infections or dermatoses, in particular mycozoonoses, cattle, equines, sheep, goats, pigs, poultry, rodents, insectivores, birds, rabbits, dogs, cats or to control Trichophyton including Trichophyton equinum, Trichophyton erinacei, Trichophyton Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton ochraceum, Trichophyton quinckeanum Trichophyton rubrum; Microsporum including Microsporum audouini, Microsporum
15 canis, Microsporum equinum, Microsporum gypseum, Microsporum nanum, Microsporum persicolor ; Dermatitis notamment Dermatitis verrucosa à Cladosporium ou à Phialophora ; dermatophilose à Dermatophilus congolensis ; ou pour apaiser ou nettoyer l'épiderme des animaux, notamment des animaux d'élevage ; pour améliorer la souplesse cutanée, calmer l'irritation, favoriser la cicatrisation, éliminer les squames et accélérer laCanis, Microsporum equinum, Microsporum gypseum, Microsporum nanum, Microsporum persicolor; Dermatitis including Dermatitis verrucosa with Cladosporium or Phialophora; dermatophilosis with Dermatophilus congolensis; or to soothe or clean the epidermis of animals, especially farm animals; to improve skin suppleness, soothe irritation, promote healing, eliminate scales and accelerate
20 repousse du poil, notamment des animaux d'élevage. 20 regrowth of the hair, especially farm animals.
L'invention concerne également une méthode de traitement pour lutter contre les mycoses ou les dermatoses humaines ou animales ou pour lutter contre les mycoses ou les dermatoses, en particulier les mycozoonoses, des bovins, des équidés, des ovins, desThe invention also relates to a method of treatment for combating mycosis or human or animal dermatoses or for combating fungal infections or dermatoses, in particular mycozoonoses, cattle, equines, sheep, sheep and goats.
25 caprins, des porcins, des volailles, des rongeurs, des insectivores, des oiseaux, des lapins, des chiens, des chats ou pour lutter contre Trichophyton notamment Trichophyton equinum, Trichophyton erinacei, Trichophyton gallinae, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton ochraceum, Trichophyton quinckeanum Trichophyton rubrum ; Microsporum notamment Microsporum audouini, MicrosporumGoats, pigs, poultry, rodents, insectivores, birds, rabbits, dogs, cats or to control Trichophyton including Trichophyton equinum, Trichophyton erinacei, Trichophyton gallinae, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton ochraceum, Trichophyton quinckeanum Trichophyton rubrum; Microsporum including Microsporum audouini, Microsporum
30 canis, Microsporum equinum, Microsporum gypseum, Microsporum nanum, Microsporum persicolor ; Dermatitis notamment Dermatitis verrucosa à Cladosporium ou à Phialophora ; dermatophilose à Dermatophilus congolensis ; pour apaiser ou nettoyer l'épiderme des animaux, notamment des animaux d'élevage ; pour améliorer la souplesse
cutanée, calmer l'irritation, favoriser la cicatrisation, éliminer les squames et accélérer la repousse du poil, notamment des animaux d'élevage ; comprenant l'application d'une composition concentrée selon l'invention ou l'application d'une formulation selon l'invention. Canis, Microsporum equinum, Microsporum gypseum, Microsporum nanum, Microsporum persicolor; Dermatitis including Dermatitis verrucosa with Cladosporium or Phialophora; dermatophilosis with Dermatophilus congolensis; to soothe or cleanse the epidermis of animals, especially farm animals; to improve flexibility cutaneous irritation, promote healing, eliminate scales and accelerate regrowth of hair, especially livestock; comprising the application of a concentrated composition according to the invention or the application of a formulation according to the invention.
5 De manière particulièrement avantageuse, la méthode selon l'invention comprend l'application réalisée par pulvérisation d'une formulation selon l'invention ou encore par l'application par pulvérisation d'une composition concentrée selon l'invention. In a particularly advantageous manner, the method according to the invention comprises the application made by spraying a formulation according to the invention or by the spray application of a concentrated composition according to the invention.
Les différents aspects de l'invention vont maintenant être décrits par des modes de î o réalisation particuliers au moyen des exemples qui suivent. The various aspects of the invention will now be described by particular embodiments by means of the following examples.
Exemple 1 : composition (CD selon l'invention Example 1 Composition (CD according to the invention
Il s'agit d'une composition comprenant des extraits de plantes obtenus à partir de feuilles fraîches d'Ilex aquifolium, de Pteridium aquilinum et d'Hypericum androseanum mises à It is a composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium, Pteridium aquilinum and Hypericum androseanum set
15 macérer dans de l'huile : 15 grammes de feuilles fraîches d'Hex aquifolium, 2 grammes de feuilles fraîches de Pteridium aquilinum et 2 grammes de feuilles fraîches d' Hypericum androseanum sont broyés pendant 15 minutes dans 600ml d'huile de paraffine (Cooper d'Exxon Mobil, densité à 20°C : 0,865g/ml et viscosté à 20°C : 176 mPa.s). Après une macération de 24 heures et une décantation de 3 heures, le surnageant est filtré. 15 maceration in oil: 15 grams of fresh leaves of Hex aquifolium, 2 grams of fresh leaves of Pteridium aquilinum and 2 grams of fresh leaves of Hypericum androseanum are ground for 15 minutes in 600ml of paraffin oil (Cooper of Exxon Mobil, density at 20 ° C: 0.865 g / ml and viscosity at 20 ° C: 176 mPa.s). After maceration for 24 hours and decantation for 3 hours, the supernatant is filtered.
20 On obtient 500 ml d'une composition concentrée (C1 ) selon l'invention. 500 ml of a concentrated composition (C1) according to the invention are obtained.
Exemple 2 : composition (C2) selon l'invention Example 2 Composition (C2) According to the Invention
Il s'agit d'une composition comprenant des extraits de plantes obtenus à partir de feuilles fraîches d'Ilex aquifolium, de Pteridium aquilinum et d'Hypericum androseanum: 15 This is a composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium, Pteridium aquilinum and Hypericum androseanum:
25 grammes de feuilles fraîches d'Ilex aquifolium, 2 grammes de feuilles fraîches de Pteridium aquilinum et 2 grammes de feuilles fraîches d' Hypericum androseanum sont broyés pendant 15 minutes. A ce broyât sont ajoutés 100 ml d'éthanol. On chauffe à reflux pendant une heure à 70°C, puis on centrifuge pendant 10 min à 5000rpm. On renouvelle la centrifugation dans les mêmes conditions. On transfère le surnageant dans25 grams of fresh leaves of Ilex aquifolium, 2 grams of fresh leaves of Pteridium aquilinum and 2 grams of fresh leaves of Hypericum androseanum are milled for 15 minutes. 100 ml of ethanol are added to this mill. The mixture is refluxed for one hour at 70 ° C. and then centrifuged for 10 minutes at 5000 rpm. Centrifugation is repeated under the same conditions. The supernatant is transferred to
30 une fiole de 200ml qu'on complète par de l'éthanol (qsp). A 200 ml flask is made up with ethanol (qs).
On obtient 200 ml d'une composition concentrée (C2) selon l'invention. 200 ml of a concentrated composition (C2) according to the invention are obtained.
Exemple 3 : composition (C3) selon l'invention
Il s'agit d'une composition comprenant des extraits de plantes obtenus à partir de feuilles fraîches d'Ilex aquifolium, de Pteridium aquilinum et d'Hypericum androseanum mises à macérer dans de l'huile et de l'ethanol: 15 grammes de feuilles fraîches d'Hex aquifolium, 2 grammes de feuilles fraîches de Pteridium aquilinum et 2 grammes de feuilles fraîches d'Hypericum androseanum sont broyés pendant 15 minutes dans 600ml d'huile de paraffine (Cooper d'Exxon Mobil, densité à 20 °C : Q865g/ml et viscosité à 20 °C : 176 mPa.s) auxquels on ajoute 3% en poids d'éthanol. Après une macération de 24 heures et une décantation de 3 heures, le surnageant est filtré. Example 3 Composition (C3) According to the Invention It is a composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium, Pteridium aquilinum and Hypericum androseanum macerated in oil and ethanol: 15 grams of leaves fresh Hex aquifolium, 2 grams of fresh leaves of Pteridium aquilinum and 2 grams of fresh leaves of Hypericum androseanum are milled for 15 minutes in 600ml of paraffin oil (Cooper of Exxon Mobil, density at 20 ° C: Q865g / ml and viscosity at 20 ° C: 176 mPa.s) to which 3% by weight of ethanol is added. After maceration for 24 hours and decantation for 3 hours, the supernatant is filtered.
On obtient 500 ml d'une composition concentrée (C3) selon l'invention. 500 ml of a concentrated composition (C3) according to the invention are obtained.
Exemple 4 : composition (C4) selon l'invention Example 4 Composition (C4) According to the Invention
Il s'agit d'une composition comprenant des extraits de plantes obtenus à partir de feuilles fraîches d'Hex aquifolium. 15 g de feuilles sont broyées pendant 15 min dans 600 ml d'huile de paraffine (densité à 20°C : 0,865g/ml et viscosité à 20 °C : 176 mPa.s) puis mises à macérer durant 24 heures avant décantation durant 3 heures. Le surnageant est alors filtré et permet d'obtenir 500 ml de composition concentrée (C4) selon l'invention. It is a composition comprising plant extracts obtained from fresh leaves of Hex aquifolium. 15 g of leaves are crushed for 15 min in 600 ml of paraffin oil (density at 20 ° C: 0.865 g / ml and viscosity at 20 ° C: 176 mPa.s) then macerated for 24 hours before settling during 3 hours. The supernatant is then filtered and makes it possible to obtain 500 ml of concentrated composition (C4) according to the invention.
Exemple 5 : composition (C5) selon l'invention Example 5 Composition (C5) According to the Invention
Il s'agit d'une composition comprenant des extraits de plantes obtenus à partir de feuilles fraîches d'Hex aquifolium : 15 grammes de feuilles fraîches d'Hex aquifolium, sont broyés pendant 15 minutes. A ce broyât sont ajoutés 100 ml d'éthanol. On chauffe à reflux pendant une heure à 70 °C, puis on centrifuge le tout pendant 10 min à 5000rpm. On renouvelle la centrifugation dans les mêmes conditions. On transfère le surnageant dans une fiole de 200ml qu'on complète par de l'éthanol (qsp). It is a composition comprising plant extracts obtained from fresh leaves of Hex aquifolium: 15 grams of fresh leaves of Hex aquifolium, are milled for 15 minutes. 100 ml of ethanol are added to this mill. The mixture is refluxed for one hour at 70 ° C. and then centrifuged for 10 minutes at 5000 rpm. Centrifugation is repeated under the same conditions. The supernatant is transferred to a 200 ml flask and made up with ethanol (qs).
On obtient 200 ml d'une composition concentrée (C5) selon l'invention 200 ml of a concentrated composition (C5) according to the invention are obtained
Exemple 6 : composition (C6) selon l'invention Example 6 Composition (C6) According to the Invention
Il s'agit d'une composition comprenant des extraits de plantes obtenus à partir de feuilles fraîches d'Hex aquifolium mises à macérer dans de l'huile et de l'éthanol: 15 grammes de feuilles fraîches d'Hex aquifolium sont broyés pendant 15 minutes dans 600ml d'huile de paraffine (Cooper d'Exxon Mobil, densité à 20 °C : Q865g/ml et viscosité à 20 °C : 176 mPa.s) auxquels on ajoute 3% en poids d'éthanol. Après une macération de 24 heures et une décantation de 3 heures, le surnageant est filtré.
On obtient 500 ml d'une composition concentrée (C6) selon l'invention. Exemple 7 : composition (C7) selon l'invention It is a composition comprising plant extracts obtained from fresh leaves of Hex aquifolium macerated in oil and ethanol: 15 grams of fresh leaves of Hex aquifolium are milled for 15 minutes. minutes in 600 ml of paraffin oil (Cooper Exxon Mobil, density at 20 ° C: Q865g / ml and viscosity at 20 ° C: 176 mPa.s) to which is added 3% by weight of ethanol. After maceration for 24 hours and decantation for 3 hours, the supernatant is filtered. 500 ml of a concentrated composition (C6) according to the invention are obtained. Example 7 Composition (C7) According to the Invention
Il s'agit d'une composition comprenant des extraits de plantes obtenus à partir de feuilles 5 fraîches d'Ilex aquifolium, de Pteridium aquilinum et d'Hypericum androseanum mises à macérer dans un ester : 15 grammes de feuilles fraîches d'Ilex aquifolium, 2 grammes de feuilles fraîches de Pteridium aquilinum et 2 grammes de feuilles fraîches d' Hypericum androseanum sont broyés pendant 15 minutes dans 600ml de myristate d'isopropyle (Produit Aroma Zone, France). Après une macération de 24 heures et une décantation de î o 3 heures, le surnageant est filtré. It is a composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium, Pteridium aquilinum and Hypericum androseanum macerated in an ester: 15 grams of fresh leaves of Ilex aquifolium, 2 grams of fresh leaves of Pteridium aquilinum and 2 grams of fresh leaves of Hypericum androseanum are milled for 15 minutes in 600ml of isopropyl myristate (Product Aroma Zone, France). After maceration for 24 hours and decantation for 3 hours, the supernatant is filtered.
On obtient 500 ml d'une composition concentrée (C7) selon l'invention. 500 ml of a concentrated composition (C7) according to the invention are obtained.
Exemple 8 : composition (C8) selon l'invention Example 8 Composition (C8) According to the Invention
Il s'agit d'une composition comprenant des extraits de plantes obtenus à partir de feuilles 15 fraîches d'Ilex aquifolium, de Pteridium aquilinum et d' Hypericum androseanum mises à macérer dans un ester et de l'éthanol: 15 grammes de feuilles fraîches d'Ilex aquifolium, 2 grammes de feuilles fraîches de Pteridium aquilinum et 2 grammes de feuilles fraîches d'Hypericum androseanum sont broyés pendant 15 minutes dans 600ml de myristate d'isopropyle (Produit Aroma Zone, France), auxquels on ajoute 3% en poids d'éthanol. 20 Après une macération de 24 heures et une décantation de 3 heures, le surnageant est filtré. This is a composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium, Pteridium aquilinum and Hypericum androseanum macerated in an ester and ethanol: 15 grams of fresh leaves of Ilex aquifolium, 2 grams of fresh leaves of Pteridium aquilinum and 2 grams of fresh leaves of Hypericum androseanum are milled for 15 minutes in 600ml of isopropyl myristate (Product Aroma Zone, France), to which is added 3% by weight ethanol. After maceration for 24 hours and decantation for 3 hours, the supernatant is filtered.
On obtient 500 ml d'une composition concentrée (C8) selon l'invention. 500 ml of a concentrated composition (C8) according to the invention are obtained.
Exemple 9 : composition (C9) selon l'invention Example 9 Composition (C9) According to the Invention
25 II s'agit d'une composition comprenant des extraits de plantes obtenus à partir de feuilles fraîches d'Ilex aquifolium. 15 g de feuilles sont broyées pendant 15 min dans 600 ml de myristate d'isopropyle (Produit Aroma Zone, France) puis mises à macérer durant 24 heures avant décantation durant 3 heures. Le surnageant est alors filtré et permet d'obtenir 500 ml de composition concentrée (C9) selon l'invention. This is a composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium. 15 g of leaves are crushed for 15 min in 600 ml of isopropyl myristate (Product Aroma Zone, France) then macerated for 24 hours before settling for 3 hours. The supernatant is then filtered and makes it possible to obtain 500 ml of concentrated composition (C9) according to the invention.
30 30
Exemple 10 : composition (C10) selon l'invention Example 10 Composition (C10) According to the Invention
Il s'agit d'une composition comprenant des extraits de plantes obtenus à partir de feuilles fraîches d'Ilex aquifolium mises à macérer dans un ester et de l'éthanol: 15 grammes de
feuilles fraîches d'Hex aquifolium sont broyés pendant 15 minutes dans 600ml de myristate d'isopropyle (Produit Aroma Zone, France) auxquels on ajoute 3% en poids d'éthanol. Après une macération de 24 heures et une décantation de 3 heures, le surnageant est filtré. It is a composition comprising plant extracts obtained from fresh leaves of Ilex aquifolium macerated in an ester and ethanol: 15 grams of Fresh leaves of Hex aquifolium are milled for 15 minutes in 600 ml of isopropyl myristate (Product Aroma Zone, France) to which 3% by weight of ethanol is added. After maceration for 24 hours and decantation for 3 hours, the supernatant is filtered.
5 On obtient 500 ml d'une composition concentrée (C6) selon l'invention. 500 ml of a concentrated composition (C6) according to the invention are obtained.
Exemple 1 1 : formulation (F1 ) selon l'invention Example 1 1: Formulation (F1) According to the Invention
De la composition concentrée obtenue à l'exemple 1 (500ml) est diluée dans de l'huile de paraffine légère (Mosselman oleochemicals, densité à 20 °C : 0,852g/ml et viscosité à î o 20°C : 29 mPa.s) jusqu'à obtenir 5 litres de formuàtion (F1 ) prête à l'emploi. The concentrated composition obtained in Example 1 (500 ml) is diluted in light paraffin oil (Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s ) until you obtain 5 liters of formula (F1) ready for use.
Exemple 12 : formulation (F2) selon l'invention Example 12: Formulation (F2) According to the Invention
De la composition concentrée obtenue à l'exemple 2 (200ml) est diluée dans de l'huile de paraffine légère (Mosselman oleochemicals, densité à 20 °C : 0,852g/ml et viscosité à 15 20°C : 29 mPa.s) jusqu'à obtenir 5 litres de formuàtion (F2) prête à l'emploi. The concentrated composition obtained in Example 2 (200 ml) is diluted in light paraffin oil (Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s) until you obtain 5 liters of formulation (F2) ready for use.
Exemple 13 : formulation (F3) selon l'invention Example 13 Formulation (F3) According to the Invention
De la composition concentrée obtenue à l'exemple 3 (500ml) est diluée dans de l'huile de paraffine légère (Mosselman oleochemicals, densité à 20 °C : 0,852g/ml et viscosité à 20 20°C : 29 mPa.s) jusqu'à obtenir 5 litres de formuàtion (F3) prête à l'emploi. The concentrated composition obtained in Example 3 (500 ml) is diluted in light paraffin oil (Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s) until you obtain 5 liters of formulation (F3) ready for use.
Exemple 14 : formulation (F4) selon l'invention EXAMPLE 14 Formulation (F4) According to the Invention
De la composition concentrée obtenue à l'exemple 5 (200ml) est diluée dans de l'huile de paraffine légère (Mosselman oleochemicals, densité à 20 °C : 0,852g/ml et viscosité à 25 20°C : 29 mPa.s) jusqu'à obtenir 5 litres de formuàtion (F4) prête à l'emploi. Un agent émulsifiant est ajouté jusqu'à obtention d'un mélange homogène et stable. The concentrated composition obtained in Example 5 (200 ml) is diluted in light paraffin oil (Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s) until you obtain 5 liters of formulation (F4) ready for use. An emulsifying agent is added until a homogeneous and stable mixture is obtained.
Exemple 15 : formulation (F5) selon l'invention Example 15 Formulation (F5) According to the Invention
De la composition concentrée obtenue à l'exemple 6 (500ml) est diluée dans de l'huile de 30 paraffine légère (Mosselman oleochemicals, densité à 20 °C : 0,852g/ml et viscosité à 20°C : 29 mPa.s) jusqu'à obtenir 5 litres de formuàtion (F5) prête à l'emploi. The concentrated composition obtained in Example 6 (500 ml) is diluted in light paraffin oil (Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s) until you obtain 5 liters of formulation (F5) ready for use.
Exemple 16 : formulation (F6) selon l'invention
De la composition concentrée obtenue à l'exemple 1 (500ml) et 250 ml de Mygliol 840 (propylène glycol diester d'acides gras d'origine végétale, saturés et à longueurs de chaînes en C8-Ci0 dont la viscosité à 20 °C est comprise entre 9 et 12 mPa.s) sont dilués dans de l'huile de paraffine légère (densité à 20°C : 0,852g/ml et viscosité à 20 °C : 29 mPa.s) jusqu'à obtenir 5 litres de formulation (F6) prête à l'emploi. Example 16: Formulation (F6) According to the Invention Of the concentrated composition obtained in Example 1 (500 ml) and 250 ml of Mygliol 840 (propylene glycol diester of vegetable fatty acids, saturated and with chain lengths C 8 -Ci 0 whose viscosity at 20 ° C is between 9 and 12 mPa.s) are diluted in light paraffin oil (density at 20 ° C: 0.852g / ml and viscosity at 20 ° C: 29 mPa.s) to obtain 5 liters formulation formulation (F6) ready for use.
Exemple 17 : formulation (F7) selon l'invention Example 17 Formulation (F7) According to the Invention
De la composition concentrée obtenue à l'exemple 4 (500ml) est diluée dans de l'huile de paraffine (densité à 20 °C : 0,865g/ml et viscosité à 20 °C : 176 mPa.s) jusqu'à obtenir 5 litres de formulation (F7) prête à l'emploi. The concentrated composition obtained in Example 4 (500 ml) is diluted in paraffin oil (density at 20 ° C: 0.865 g / ml and viscosity at 20 ° C: 176 mPa.s) to obtain 5 liters of formulation (F7) ready for use.
Exemple 18 : formulation (F8) selon l'invention Example 18: Formulation (F8) According to the Invention
De la composition concentrée obtenue à l'exemple 9 (500ml) est diluée dans de l'huile de paraffine légère (Mosselman oleochemicals, densité à 20 °C : 0,852g/ml et viscosité à 20°C : 29 mPa.s) jusqu'à obtenir 5 litres de formuàtion (F8) prête à l'emploi. The concentrated composition obtained in Example 9 (500 ml) is diluted in light paraffin oil (Mosselman oleochemicals, density at 20 ° C: 0.852 g / ml and viscosity at 20 ° C: 29 mPa.s) to obtain 5 liters of formulation (F8) ready for use.
Exemple 19 : Efficacité contre la teigne du bovin Example 19 Effectiveness Against Ringworm in Cattle
Il s'agit d'un essai préliminaire d'efficacité de la formulation (F7) de I'exemple17 pour le traitement de vaches d'élevage de race Holstein. This is a preliminary efficacy test of formulation (F7) of Example 17 for the treatment of Holstein breeding cows.
Les vaches présentent des plaques de forme ronde caractéristiques de la teigne (Trichophyon verrucosum). The cows have round-shaped plates characteristic of ringworm (Trichophyon verrucosum).
On recouvre les plaques de teigne par de la formulation. Le traitement est renouvelé trois jours après la première application. The ringlets are covered with the formulation. The treatment is renewed three days after the first application.
La formulation permet d'éliminer l'ensemble des plaques de teigne. The formulation eliminates all the ringworm plates.
Exemple 20 : Efficacité contre la teigne touchant une personne Example 20: Efficacy against ringworm affecting a person
Il s'agit d'un essai préliminaire d'efficacité de la formulation (F7) de l'exemple 17 pour le traitement d'une toiletteuse pour animaux de compagnie en contact fréquent avec des chiens et des chats. This is a preliminary efficacy test of formulation (F7) of Example 17 for the treatment of a pet groomer in frequent contact with dogs and cats.
La toiletteuse présente sur l'avant-bras des plaques de forme ronde caractéristiques de la teigne (Microsporum canis). The groomer presents on the forearm round-shaped plates characteristic of ringworm (Microsporum canis).
On recouvre les plaques de teigne par de la formulation. Le traitement est renouvelé trois jours après la première application.
La formulation n'entraine aucune réaction cutanée et permet d'éliminer l'ensemble des plaques de teigne. Aucune plaque n'est visible une semaine après le début du traitement. The ringlets are covered with the formulation. The treatment is renewed three days after the first application. The formulation causes no skin reaction and eliminates all ringworm. No plaque is visible one week after the start of treatment.
Exemple 21 : Efficacité contre la teigne et contre la gale de boue de chevaux Example 21 Effectiveness Against Ringworm and Horse Mange Mite
5 II s'agit d'un autre essai préliminaire d'efficacité de la formulation (F7) de l'exemple 17 pour le traitement de chevaux d'écurie (En Gautier à Montbrun-Lauragais, France). This is another preliminary test of the effectiveness of formulation (F7) of Example 17 for the treatment of stable horses (En Gautier in Montbrun-Lauragais, France).
Les cinq chevaux traités présentent des problèmes de gale de boue (Dermatitis verrucosa à Cladosporium ou à Phialophora, dermatophilose à Dermatophilus congolensis) et de teigne ( Trichophyton equinus). The five treated horses have problems with mud mange (Dermatitis verrucosa with Cladosporium or Phialophora, dermatophilosis with Dermatophilus congolensis) and ringworm (Trichophyton equinus).
î o On traite les paturons des chevaux atteints par la gale de boue et on recouvre les plaques de teigne par de la formulation selon l'invention. Le traitement est renouvelé trois jours après la première application. Les chevaux ne présentent aucune réaction cutanée. A la suite du traitement, les traces de gale de boue et les plaques de teigne ont totalement disparu. Ces résultats ont été obtenus en 10 jours après le début duThe pasterns of the horses affected by the mud scab are treated and the ring-worm plates are covered with the formulation according to the invention. The treatment is renewed three days after the first application. Horses have no skin reaction. As a result of the treatment, the traces of mud mange and ringworm have completely disappeared. These results were obtained in 10 days after the start of
15 traitement. Treatment.
La formulation permet donc d'éliminer rapidement l'ensemble des traces de gale de boue ainsi que les plaques de teigne. The formulation thus makes it possible to rapidly eliminate all the traces of mud mange as well as the ring-worm plates.
Exemple 22 : Efficacité contre Trichophyton verrucosum sur bovins Example 22: Effectiveness against Trichophyton verrucosum on cattle
20 II s'agit d'un essai portant sur 30 jeunes bovins de races montbéliarde, Holstein ou croisées charollais/montbéliarde atteints de teignes ( Trichophyton verrucosum). 20 This is an experiment involving 30 young cattle of Montbeliarde, Holstein or cross-breed Charollais / Montbeliarde breeds with moths (Trichophyton verrucosum).
Un premier lot de 10 bovins a été traité avec une formulation (F1 ) selon l'exemple 1 1 , un deuxième lot de 10 bovins a été traité avec une formulation (F2) selon l'exemple 12 et un lot de 10 bovins a été traité avec un produit vétérinaire de référence. Ce produit 25 vétérinaire de référence pour le traitement de Trichophyton verrucosum comprend de l'enilconazole (produit commercial Imaveral) et a été utilisé selon les conditions préconisées. A first batch of 10 cattle was treated with a formulation (F1) according to Example 1 1, a second batch of 10 cattle was treated with a formulation (F2) according to Example 12 and a batch of 10 cattle was treated with a veterinary reference product. This veterinary reference product for the treatment of Trichophyton verrucosum comprises enilconazole (Imaveral commercial product) and has been used according to the recommended conditions.
Protocole : Protocol:
Les traitements ont été réalisés par pulvérisation des animaux (sur les lésions et sur une 30 zone de 3 cm autour des lésions). The treatments were carried out by spraying the animals (on the lesions and on an area of 3 cm around the lesions).
Les formulations (F1 ) et (F2) ont été appliquées 2 fois à 4 jours d'intervalle. Formulations (F1) and (F2) were applied twice 4 days apart.
Le produit de référence à base d'enilconazole a été appliqué 4 fois à 4 jours d'intervalle en respectant les taux de dilution préconisés.
Résultats : The reference product containing enilconazole was applied 4 times at 4 days intervals respecting the recommended dilution rates. Results:
Le suivi de cet essai a été réalisé par une vétérinaire indépendante en charge du suivi de l'élevage. Elle a assuré une notation individuelle de chaque animal selon 3 critères : alopécie, croûtes et squames aux jours 1 , 5, 9, 13, 22 et 30. The follow-up of this trial was carried out by an independent veterinarian in charge of monitoring the breeding. She gave an individual rating of each animal according to 3 criteria: alopecia, crusts and scales on days 1, 5, 9, 13, 22 and 30.
Une note de 0 correspond à une absence de signe visuel d'atteinte, une note de 1 correspond à une atteinte faible, une note de 2 correspond à une atteinte modérée et une note de 3 correspond à une atteinte sévère (alopécie). La note attribuée correspond à une note cumulée des trois critères. A score of 0 corresponds to an absence of a visual sign of impairment, a score of 1 corresponds to a weak impairment, a score of 2 corresponds to a moderate impairment and a score of 3 corresponds to a severe impairment (alopecia). The score awarded corresponds to an overall score of the three criteria.
Les résultats obtenus après ces évaluations ont été rassemblés dans le tableau 1 sous la forme de scores moyens. The results obtained after these evaluations were collated in Table 1 in the form of mean scores.
Conclusion : Conclusion:
Tous les animaux traités ont été guéris. La guérison a été plus rapide pour les lots traités suite à 2 applications de formulations (F1 ) ou (F2) selon l'invention. Comparativement, le lot de bovins traités par 4 applications d'enilconazole n'a pas montré de meilleurs résultats. All treated animals were cured. Healing was faster for the batches treated following two applications of formulations (F1) or (F2) according to the invention. Comparatively, the batch of cattle treated with 4 applications of enilconazole did not show better results.
Ainsi, il n'a pas été mis en évidence de différence significative sur l'ensemble de la durée de l'essai entre les 2 lots de bovins traités selon la méthode de l'invention et le traitement vétérinaire de référence. Thus, no significant difference was found over the entire duration of the trial between the 2 batches of cattle treated according to the method of the invention and the reference veterinary treatment.
De plus, aucun problème d'intolérance n'a été noté pour les traitements au moyen des formulations selon l'invention. In addition, no problem of intolerance was noted for the treatments using the formulations according to the invention.
Enfin, il a été noté la supériorité des formulations selon l'invention quant à leur utilisation plus pratique : temps et nombre d'applications réduits de 50% pour les deux
formulations selon l'invention mises en œuvre, produit prêt à l'emploi plutôt qu'un produit de référence nécessitant une dilution préalable à l'application, meilleure fixation aux lésions des formulations selon l'invention.
Finally, it was noted the superiority of the formulations according to the invention as to their more practical use: time and number of applications reduced by 50% for both formulations according to the invention implemented, ready-to-use product rather than a reference product requiring dilution prior to application, better binding to the lesions of the formulations according to the invention.
Claims
1 . Composition concentrée comprenant au moins un extrait d'une plante du genre //ex en une concentration allant de 5 à 80 g/l. 1. Concentrated composition comprising at least one extract of a plant of the genus //ex in a concentration ranging from 5 to 80 g/l.
2. Composition selon la revendication 1 comprenant au moins un extrait d'une plante du genre //ex en une concentration allant de 5 à 80 g/l, à l'exclusion d'un extrait de fruits d'une plante du genre //ex. 2. Composition according to claim 1 comprising at least one extract of a plant of the genus //ex in a concentration ranging from 5 to 80 g/l, excluding an extract of fruits of a plant of the genus / /ex.
3. Composition selon les revendications 1 et 2 comprenant au moins un extrait de feuilles fraîches ou de feuilles fraîches surgelées d'une plante du genre //ex en une concentration allant de 5 à 80 g/l. 3. Composition according to claims 1 and 2 comprising at least one extract of fresh leaves or fresh frozen leaves of a plant of the genus //ex in a concentration ranging from 5 to 80 g/l.
4. Composition selon les revendications 1 à 3 pour laquelle la plante est choisie parmi //ex aquifolium, //ex aquiliformis, //ex guayusa, //ex paraguariensis, //ex vomitoria ou pour laquelle l'extrait de plante est présent en une concentration allant de 15 à 60 g/l ou de 25 à 45 g/l ou bien est de 30 g/l. 4. Composition according to claims 1 to 3 for which the plant is chosen from //ex aquifolium, //ex aquiliformis, //ex guayusa, //ex paraguariensis, //ex vomitoria or for which the plant extract is present in a concentration ranging from 15 to 60 g/l or from 25 to 45 g/l or is 30 g/l.
5. Composition selon les revendications 1 à 4 comprenant également au moins un extrait d'une plante du genre Pteridium ou au moins un extrait d'une plante du genre Hypericum ou comprenant également au moins un extrait d'une plante du genre Pteridium et au moins un extrait d'une plante du genre Hypericum. 5. Composition according to claims 1 to 4 also comprising at least one extract of a plant of the genus Pteridium or at least one extract of a plant of the genus Hypericum or also comprising at least one extract of a plant of the genus Pteridium and least one extract of a plant of the genus Hypericum.
6. Composition selon les revendications 1 à 5 comprenant également au moins un extrait d'une plante choisie parmi Pteridium aquilifolium, Pteridium aquiliformis, Pteridium aquilinum, ou au moins un extrait d'une plante choisie parmi Hypericum androseanum, Hypericum perforatum. 6. Composition according to claims 1 to 5 also comprising at least one extract of a plant chosen from Pteridium aquilifolium, Pteridium aquiliformis, Pteridium aquilinum, or at least one extract of a plant chosen from Hypericum androseanum, Hypericum perforatum.
7. Composition selon les revendications 1 à 6 comprenant 7. Composition according to claims 1 to 6 comprising
• un extrait d'//ex aquifolium en une concentration allant de 25 à 45 g/l ; • an extract of //ex aquifolium in a concentration ranging from 25 to 45 g/l;
• un extrait de Pteridium aquilinum en une concentration allant de 3 à 10 g/l ; • an extract of Pteridium aquilinum in a concentration ranging from 3 to 10 g/l;
• un extrait d'Hypericum perforatum en une concentration allant de 3 à 10 g/l ; • an extract of Hypericum perforatum in a concentration ranging from 3 to 10 g/l;
ou comprenant
• un extrait d'Ilex aquifolium en une concentration allant de 25 à 45 g/l ; or including • an extract of Ilex aquifolium in a concentration ranging from 25 to 45 g/l;
• un extrait de Pteridium aquilinum en une concentration allant de 3 à 10 g/l ; • an extract of Pteridium aquilinum in a concentration ranging from 3 to 10 g/l;
• un extrait d'Hypericum androseanum en une concentration allant de 3 à 10 g/l. • an extract of Hypericum androseanum in a concentration ranging from 3 to 10 g/l.
8. Composition selon les revendications 1 à 7 comprenant également un support choisi parmi 8. Composition according to claims 1 to 7 also comprising a support chosen from
• les huiles de paraffine épaisses ou les huiles de paraffine dont la densité à 20 °C est comprise entre 0,860 et 0,890 g/ml et dont la viscosité à 20 °C est comprise entre 100 mPa.s et 250 mPa.s ou les huiles de paraffine dont la densité à 20°C est comprise entre 0,862 et 0,875 g/ml et dont la viscosité à 20 °C est comprise entre 140 mPa.s et 185 mPa.s ; • thick paraffin oils or paraffin oils whose density at 20°C is between 0.860 and 0.890 g/ml and whose viscosity at 20°C is between 100 mPa.s and 250 mPa.s or oils paraffin whose density at 20°C is between 0.862 and 0.875 g/ml and whose viscosity at 20°C is between 140 mPa.s and 185 mPa.s;
• les huiles de paraffine légères ou les huiles de paraffine dont la densité à 20 °C est comprise entre 0,810 et 0,855 g/ml et dont la viscosité à 20 °C est comprise entre 10 mPa.s et 90 mPa.s ou les huiles de paraffine dont la densité à 20°C est comprise entre 0,850 et 0,853 g/ml et dont la viscosité à 20 °C est comprise entre 25 mPa.s et 35 mPa.s ; • light paraffin oils or paraffin oils whose density at 20°C is between 0.810 and 0.855 g/ml and whose viscosity at 20°C is between 10 mPa.s and 90 mPa.s or oils paraffin whose density at 20°C is between 0.850 and 0.853 g/ml and whose viscosity at 20°C is between 25 mPa.s and 35 mPa.s;
• les composés de formule (I) • the compounds of formula (I)
dans laquelle in which
R représente un groupement C C20 alkyl, de préférence un groupement C8-Ci5 alkyl, en particulier un groupement Ci3 alkyl, de préférence un groupement n- tridecanyl ; R represents a CC 20 alkyl group, preferably a C 8 -Ci 5 alkyl group, in particular a Ci 3 alkyl group, preferably an n-tridecanyl group;
R2 représente un groupement C C20 alkyl, de préférence un groupement C C6 alkyl, en particulier un groupement C3 alkyl, de préférence un groupement isopropyl ; R 2 represents a CC 20 alkyl group, preferably a CC 6 alkyl group, in particular a C 3 alkyl group, preferably an isopropyl group;
en particulier le myristate d'isopropyle ou tétradécanoate de propan-2-yle ; in particular isopropyl myristate or propan-2-yl tetradecanoate;
• le glycerol ou propane-1 ,2,3-triol ; • glycerol or propane-1,2,3-triol;
• l'un ou l'autre de ces supports et un alcool choisi parmi le méthanol, l'éthanol, le n- propanol, l'isopropanol, le n-butanol et l'isobutanol, de préférence l'éthanol ; • one or other of these supports and an alcohol chosen from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol;
• un alcool choisi parmi le méthanol, l'éthanol, le n-propanol, l'isopropanol, le n- butanol et l'isobutanol, de préférence l'éthanol.
• an alcohol chosen from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol.
9. Formulation comprenant une composition selon les revendications 1 à 8 et un support choisi parmi les huiles de paraffine légères ou les huiles de paraffine dont la densité à 20°C est comprise entre 0,845 et 0,855 g/ml et dont la viscosité à 20°C est comprise 5 entre 10 mPa.s et 90 mPa.s ou les huiles de paraffine dont la densité à 20 °C est comprise entre 0,850 et 0,853 g/ml et dont la viscosité à 20 °C est comprise entre 25 mPa.s et 35 mPa.s ; le myristate d'isopropyle ou tétradécanoate de propan-2-yle ; le glycerol ou propane-1 ,2,3-triol. î o9. Formulation comprising a composition according to claims 1 to 8 and a support chosen from light paraffin oils or paraffin oils whose density at 20°C is between 0.845 and 0.855 g/ml and whose viscosity at 20°C C is between 10 mPa.s and 90 mPa.s or paraffin oils whose density at 20°C is between 0.850 and 0.853 g/ml and whose viscosity at 20°C is between 25 mPa.s and 35 mPa.s; isopropyl myristate or propan-2-yl tetradecanoate; glycerol or propane-1,2,3-triol. î o
10. Formulation selon la revendication 9 comprenant de 5 à 30% de composition selon les revendications 1 à 8 et de 70 à 95% de support ou de 70 à 95% de support et d'un agent émollient ou de propylène glycol diester d'acides gras d'origine végétale, saturés et à longueurs de chaînes en C8-Ci0. 10. Formulation according to claim 9 comprising from 5 to 30% of composition according to claims 1 to 8 and from 70 to 95% of support or from 70 to 95% of support and an emollient agent or propylene glycol diester of fatty acids of plant origin, saturated and with C 8 -Ci 0 chain lengths.
15 1 1 . Procédé (P1 ) de préparation d'une composition concentrée comprenant 15 1 1 . Process (P1) for preparing a concentrated composition comprising
• le broyage, par exemple dans les trois jours suivants la récolte ou pendant une durée allant de 5 à 45 min ou pendant une durée allant de 10 à 25 min, de feuilles fraîches ou de feuilles fraîches surgelées d'au moins une plante définie selon les revendications 1 à 8 ; • crushing, for example within three days following harvest or for a period ranging from 5 to 45 min or for a period ranging from 10 to 25 min, of fresh leaves or fresh frozen leaves of at least one plant defined according to claims 1 to 8;
20 « la macération du broyât, par exemple pendant une durée allant de 6 à 36 h ou pendant une durée allant de 18 à 30 h, dans un support choisi parmi o les huiles de paraffine épaisses ou les huiles de paraffine dont la densité à 20 "maceration of the ground material, for example for a period ranging from 6 to 36 hours or for a period ranging from 18 to 30 hours, in a support chosen from o thick paraffin oils or paraffin oils whose density at
20°C est comprise entre 0,860 et 0,890 g/ml et dont la viscosité à 20 °C est comprise entre 100 mPa.s et 250 mPa.s ou les huiles de paraffine dont la 25 densité à 20°C est comprise entre 0,862 et 0,875 g/fml et dont la viscosité à 20°C is between 0.860 and 0.890 g/ml and whose viscosity at 20°C is between 100 mPa.s and 250 mPa.s or paraffin oils whose density at 20°C is between 0.862 and 0.875 g/fml and whose viscosity at
20 °C est comprise entre 140 mPa.s et 185 mPa.s ; 20°C is between 140 mPa.s and 185 mPa.s;
o les huiles de paraffine légères ou les huiles de paraffine dont la densité à 20 °C est comprise entre 0,810 et 0,855 g/ml et dont la viscosité à 20 °C est comprise entre 10 mPa.s et 90 mPa.s ou les huiles de paraffine dont la densité à 20°C 30 est comprise entre 0,850 et 0,853 g/ml et dont la viscosité à 20 °C est comprise entre 25 mPa.s et 35 mPa.s ; o light paraffin oils or paraffin oils whose density at 20°C is between 0.810 and 0.855 g/ml and whose viscosity at 20°C is between 10 mPa.s and 90 mPa.s or oils paraffin whose density at 20°C is between 0.850 and 0.853 g/ml and whose viscosity at 20°C is between 25 mPa.s and 35 mPa.s;
dans laquelle in which
R1 représente un groupement C C20 alkyl, de préférence un groupement C8- C15 alkyl, en particulier un groupement Ci3 alkyl, de préférence un groupement n-tridecanyl ; R 1 represents a CC 20 alkyl group, preferably a C 8 - C15 alkyl group, in particular a Ci 3 alkyl group, preferably an n-tridecanyl group;
R2 représente un groupement C C20 alkyl, de préférence un groupement Ci - Ce alkyl, en particulier un groupement C3 alkyl, de préférence un groupement isopropyl ; R 2 represents a CC 20 alkyl group, preferably a Ci - Ce alkyl group, in particular a C 3 alkyl group, preferably an isopropyl group;
en particulier le myristate d'isopropyle ou tétradécanoate de propan-2-yle ; o le glycerol ou propane-1 ,2,3-triol ; in particular isopropyl myristate or propan-2-yl tetradecanoate; o glycerol or propane-1,2,3-triol;
o l'un ou l'autre de ces supports et un alcool choisi parmi le méthanol, l'éthanol, le n-propanol, l'isopropanol, le n-butanol et l'isobutanol, de préférence l'éthanol ; o one or other of these supports and an alcohol chosen from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol;
o un alcool choisi parmi le méthanol, l'éthanol, le n-propanol, l'isopropanol, le n- butanol et l'isobutanol, de préférence l'éthanol ; o an alcohol chosen from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol;
• la décantation, par exemple pendant une durée allant de 30 min à 24 h ou pendant une durée allant de 4 à 8 h ; • decantation, for example for a period ranging from 30 min to 24 hours or for a period ranging from 4 to 8 hours;
• puis la filtration du produit de la macération. • then filtration of the maceration product.
12. Procédé (P2) de préparation d'une composition concentrée comprenant 12. Process (P2) for preparing a concentrated composition comprising
• le broyage de feuilles fraîches ou de feuilles fraîches surgelées d'au moins une plante définie selon les revendications 1 à 8 ; • grinding fresh leaves or fresh frozen leaves of at least one plant defined according to claims 1 to 8;
• le chauffage du broyât dans un alcool choisi parmi le méthanol, l'éthanol, le n- propanol, l'isopropanol, le n-butanol et l'isobutanol, de préférence l'éthanol ; • heating the ground material in an alcohol chosen from methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol, preferably ethanol;
• la centrifugation du produit de chauffage ; • centrifugation of the heating product;
• la séparation du surnageant.
• separation of the supernatant.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1354478A FR3005578B1 (en) | 2013-05-17 | 2013-05-17 | COMPOSITION OF ILEX AQUIFOLIUM EXTRACTS AND USE THEREOF |
FR1354478 | 2013-05-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014184340A1 true WO2014184340A1 (en) | 2014-11-20 |
Family
ID=49111364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2014/060070 WO2014184340A1 (en) | 2013-05-17 | 2014-05-16 | Composition of ilex aquifolium extracts and use thereof |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3005578B1 (en) |
WO (1) | WO2014184340A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016148813A1 (en) * | 2015-03-19 | 2016-09-22 | KARBSTEIN, Aicy | Plant extract for hair tonic for treating baldness and preventing hair loss, and hair bulb regenerator |
WO2019174786A1 (en) | 2018-03-16 | 2019-09-19 | Centre National De La Recherche Scientifique | Use of an ilex aquifolium extract for treating skin pigmentation disorders and for skin whitening |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109259136A (en) * | 2018-10-30 | 2019-01-25 | 四川峨边五旺有限责任公司 | A kind of instant fiddlehead and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5958395A (en) * | 1996-02-22 | 1999-09-28 | Wella Aktiengesellschaft | Cosmetic preparation containing Ilex resin, method of obtaining Ilex and Ilex resin obtained thereby |
CN101791324A (en) * | 2010-04-07 | 2010-08-04 | 苏州瑞得符生物科技有限公司 | Preparation process of Ilex latifolia Thunb extractive |
CN101856376A (en) * | 2009-04-11 | 2010-10-13 | 张毅 | Chinese medicament for treating dermatophytosis |
CN102813797A (en) * | 2012-08-01 | 2012-12-12 | 赵庆军 | Preparation method of traditional Chinese medicine for treating intemperance type insomnia |
-
2013
- 2013-05-17 FR FR1354478A patent/FR3005578B1/en not_active Expired - Fee Related
-
2014
- 2014-05-16 WO PCT/EP2014/060070 patent/WO2014184340A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5958395A (en) * | 1996-02-22 | 1999-09-28 | Wella Aktiengesellschaft | Cosmetic preparation containing Ilex resin, method of obtaining Ilex and Ilex resin obtained thereby |
CN101856376A (en) * | 2009-04-11 | 2010-10-13 | 张毅 | Chinese medicament for treating dermatophytosis |
CN101791324A (en) * | 2010-04-07 | 2010-08-04 | 苏州瑞得符生物科技有限公司 | Preparation process of Ilex latifolia Thunb extractive |
CN102813797A (en) * | 2012-08-01 | 2012-12-12 | 赵庆军 | Preparation method of traditional Chinese medicine for treating intemperance type insomnia |
Non-Patent Citations (6)
Title |
---|
DATABASE WPI Week 201058, Derwent World Patents Index; AN 2010-K99583, XP002715649 * |
DATABASE WPI Week 201334, Derwent World Patents Index; AN 2013-G64987, XP002727086 * |
ERDEMOGLU NURGUEN ET AL: "Antibacterial, antifungal, and antimycobacterial activity of Ilex aquifolium leaves", PHARMACEUTICAL BIOLOGY, SWETS AND ZEITLINGER, LISSE, NL, vol. 47, no. 8, 1 August 2009 (2009-08-01), pages 697 - 700, XP009160846, ISSN: 1388-0209, DOI: 10.1080/13880200902930431 * |
HARAGUCHI H ET AL: "ANTIMICROBIAL TRITERPENES FROM IIEX INTEGRA AND THE MECHANISM OF ANTIFUNGAL ACTION", PHYTOTHERAPY RESEARCH, JOHN WILEY & SONS LTD. CHICHESTER, GB, vol. 13, no. 2, 1 January 1999 (1999-01-01), pages 151 - 156, XP001061579, ISSN: 0951-418X, DOI: 10.1002/(SICI)1099-1573(199903)13:2<151::AID-PTR391>3.3.CO;2-3 * |
IGNACIO N. PERALTA ET AL: "Prevention of Hydrogen Peroxide-Induced Red Blood Cells Lysis by Ilex paraguariensis Aqueous Extract: Participation of Phenolic and Xanthine Compounds", PHYTOTHERAPY RESEARCH, vol. 27, no. 2, 18 April 2012 (2012-04-18), pages 192 - 198, XP055128560, ISSN: 0951-418X, DOI: 10.1002/ptr.4700 * |
ROSANA FILIP ET AL: "Antifungal activity of the aqueous extract of Ilex paraguariensis against Malassezia furfur", PHYTOTHERAPY RESEARCH, vol. 24, no. 5, 1 May 2010 (2010-05-01), pages n/a - n/a, XP055085586, ISSN: 0951-418X, DOI: 10.1002/ptr.3004 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016148813A1 (en) * | 2015-03-19 | 2016-09-22 | KARBSTEIN, Aicy | Plant extract for hair tonic for treating baldness and preventing hair loss, and hair bulb regenerator |
US9849078B2 (en) | 2015-03-19 | 2017-12-26 | Franklin Kilbert Karbstein | Plant extract for hair tonic for treating baldness and preventing hair loss and hair bulb regenerator |
WO2019174786A1 (en) | 2018-03-16 | 2019-09-19 | Centre National De La Recherche Scientifique | Use of an ilex aquifolium extract for treating skin pigmentation disorders and for skin whitening |
FR3078891A1 (en) * | 2018-03-16 | 2019-09-20 | Centre National De La Recherche Scientifique (Cnrs) | USE OF ILEX AQUIFOLIUM EXTRACT FOR THE TREATMENT OF PIGMENTATION DISORDERS AND SKIN LAUNDERING |
Also Published As
Publication number | Publication date |
---|---|
FR3005578B1 (en) | 2015-06-05 |
FR3005578A1 (en) | 2014-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0147261B1 (en) | Medicine and medicinal composition for the treatment and the prevention of skin affections involving an inflammation process | |
WO2021156104A1 (en) | Method for obtaining an aqueous extract of lavender, compositions comprising such an extract and their cosmetic uses | |
WO2014184340A1 (en) | Composition of ilex aquifolium extracts and use thereof | |
EP3681462A1 (en) | Oil solution of benzyl alcohol, and use in the prevention and treatment of parasitoses | |
EP3089751B1 (en) | Topical composition comprising extracts of boldo and of meadowsweet, intended for an animal, and uses thereof | |
WO2002098404A1 (en) | Topical compositions for veterinary uses | |
WO1998018479A1 (en) | Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract | |
DE102006018178A1 (en) | Animal feed obtained from Aloe vera as gel, concentrate, essence and/or as original source material for the following animals e.g. cats, dogs, rabbits, mice, sea pigs, snakes, reptiles, spiders, rats, insects camels, alpacas and horses | |
CA2027723A1 (en) | Use of glycoproteins extracted from gram-negative bacteria to produce cosmetic or dermatologic compositions, and compositions containing them | |
EP4058009B1 (en) | Rinsable oily solution for controlling lice | |
EP0308456B1 (en) | Compositon for the treatment of the epiderm | |
JP2003160502A (en) | Production method of active fraction obtained from pyroligneous acid and utilization thereof | |
FR2887456A1 (en) | "COMPOSITION FOR THE TREATMENT OF THE SUMMER DERMITE" | |
JP6655296B2 (en) | Hair growth or hair growth promoter | |
EP0566495A1 (en) | Potentiation of pyrethrinoid by crotamiton, useful for the treatment of pediculosis | |
FR2747308A1 (en) | Use of azadirachta indica, hydroxycitrate, ceramides and optionally vitamins or caffeine | |
FR3066392A1 (en) | COMPOSITION BASED ON PLANT COMPONENTS FOR TREATING OR TREATING SKIN AND / OR HAIR IN ANIMALS | |
EP3319584B1 (en) | Use of n-alkyl amide as an antiperspirant agent | |
RU2045948C1 (en) | Hair growth stimulator | |
JP2006137834A (en) | Purified pyroligneous acid, preparation method therefor and cosmetic, antibacterial agent, pharmaceutical product and processed food using the same | |
FR3029739A1 (en) | USE OF EVODONE DERIVATIVES AS REPELLENT, NEW EVODONE DERIVATIVES AND SYNTHESIS METHOD | |
Viste et al. | Efficacy test and acceptability of Kakawate (Gliricidia sepium) leaf extract soap against mange in dogs | |
EP3134382B1 (en) | Novel derivatives of benzyl benzoate | |
WO2000033666A1 (en) | Energetic feed for livestock | |
WO2021048305A1 (en) | Repellent composition and uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14726914 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14726914 Country of ref document: EP Kind code of ref document: A1 |